cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
KIRP	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-17.63	1.62e-46	-0.92	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-17.63	1.62e-46	-0.92	-0.74	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	17.59	2.27e-46	0.94	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	17.59	2.27e-46	0.94	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-17.55	3.13e-46	-0.93	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-17.55	3.13e-46	-0.93	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-17.55	3.13e-46	-0.93	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-17.55	3.13e-46	-0.93	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-17.42	9.26e-46	-0.94	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-17.42	9.26e-46	-0.94	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-17.04	1.93e-44	-0.94	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-17.04	1.93e-44	-0.94	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-16.89	6.96e-44	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-16.89	6.96e-44	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-16.89	6.96e-44	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-16.89	6.96e-44	-0.93	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-16.86	8.75e-44	-0.94	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-16.86	8.75e-44	-0.94	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	16.83	1.08e-43	0.93	0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	16.83	1.08e-43	0.93	0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-16.68	3.9e-43	-0.92	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-16.68	3.9e-43	-0.92	-0.72	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-16.36	5.08e-42	-0.92	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-16.36	5.08e-42	-0.92	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-16.13	3.46e-41	-0.93	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-16.13	3.46e-41	-0.93	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-15.93	1.7e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-15.93	1.7e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-15.93	1.7e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-15.93	1.7e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-15.92	1.78e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-15.92	1.78e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-15.92	1.78e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-15.92	1.78e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-15.8	4.78e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-15.8	4.78e-40	-0.92	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-15.75	7.08e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-15.75	7.08e-40	-0.94	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-15.59	2.81e-39	-0.92	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-15.59	2.81e-39	-0.92	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-15.25	4.51e-38	-0.9	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-15.25	4.51e-38	-0.9	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-14.87	9.45e-37	-0.89	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-14.87	9.45e-37	-0.89	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-14.83	1.37e-36	-0.87	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-14.83	1.37e-36	-0.87	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
KIRP	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	11.88	2.3e-26	1	0.59	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	11.88	2.3e-26	1	0.59	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	11.76	5.85e-26	0.99	0.59	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	11.73	7.31e-26	1.01	0.59	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	11.66	1.29e-25	1	0.58	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	11.44	7.04e-25	0.99	0.58	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	11.44	7.04e-25	0.99	0.58	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	11.16	6.02e-24	0.9	0.57	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	10.86	5.87e-23	0.87	0.56	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	10.37	2.42e-21	0.84	0.54	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	10.33	3.13e-21	0.82	0.54	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	10.29	4.27e-21	0.82	0.53	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	10.29	4.27e-21	0.82	0.53	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	10.29	4.27e-21	0.82	0.53	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	10.28	4.68e-21	0.81	0.53	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	10.24	6.33e-21	0.82	0.53	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	10.23	6.8e-21	0.81	0.53	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	10.21	7.49e-21	0.82	0.53	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	10.13	1.36e-20	0.81	0.53	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	10.13	1.36e-20	0.81	0.53	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	10.02	3.19e-20	0.81	0.52	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	9.74	2.31e-19	0.8	0.51	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	9.74	2.31e-19	0.8	0.51	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
KIRP	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	9.6	6.44e-19	0.77	0.51	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	9.54	1e-18	1.09	0.51	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	9.4	2.76e-18	1.1	0.5	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	9.4	2.76e-18	1.1	0.5	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	9.25	7.76e-18	1.08	0.49	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
KIRP	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-9.17	1.36e-17	-0.78	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-9.17	1.36e-17	-0.78	-0.49	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
KIRP	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	8.82	1.58e-16	0.74	0.48	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	8.69	3.93e-16	0.83	0.47	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	8.53	1.13e-15	0.8	0.46	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	8.51	1.36e-15	0.81	0.46	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	8.51	1.36e-15	0.81	0.46	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	8.51	1.36e-15	0.81	0.46	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	8.47	1.78e-15	0.81	0.46	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	8.47	1.78e-15	0.81	0.46	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	8.47	1.78e-15	0.81	0.46	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	8.47	1.78e-15	0.81	0.46	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	8.46	1.87e-15	0.79	0.46	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	8.43	2.31e-15	0.82	0.46	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	8.43	2.31e-15	0.82	0.46	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	8.43	2.31e-15	0.82	0.46	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	8.43	2.31e-15	0.81	0.46	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	8.42	2.42e-15	0.8	0.46	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	8.38	3.13e-15	0.82	0.46	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	8.31	5.17e-15	0.8	0.46	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	8.28	6.01e-15	0.8	0.45	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-8.27	6.57e-15	-0.77	-0.45	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	8.27	6.64e-15	0.8	0.45	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	8.26	7.26e-15	0.81	0.45	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	8.25	7.42e-15	0.81	0.45	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	8.25	7.83e-15	0.79	0.45	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	8.24	8.09e-15	0.79	0.45	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	8.24	8.09e-15	0.79	0.45	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	8.23	8.47e-15	0.8	0.45	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	8.23	8.47e-15	0.8	0.45	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	8.23	8.47e-15	0.8	0.45	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	8.23	8.55e-15	0.78	0.45	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	8.22	9.07e-15	0.81	0.45	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	8.22	9.07e-15	0.81	0.45	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	8.22	9.07e-15	0.81	0.45	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	8.22	9.07e-15	0.81	0.45	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	8.22	9.25e-15	0.8	0.45	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	8.22	9.38e-15	0.79	0.45	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	8.17	1.26e-14	0.8	0.45	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	8.16	1.38e-14	0.8	0.45	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	8.16	1.41e-14	0.8	0.45	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	8.13	1.73e-14	0.8	0.45	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	8.13	1.73e-14	0.8	0.45	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	8.11	1.86e-14	0.8	0.45	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
KIRP	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	8.08	2.3e-14	0.64	0.45	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
KIRP	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	8.07	2.45e-14	0.78	0.44	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	8.06	2.63e-14	0.79	0.44	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	7.93	6.2e-14	0.77	0.44	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	7.93	6.2e-14	0.77	0.44	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
KIRP	cis	rs754133	0.891	rs12426399	MIMAT0004562	hsa-miR-196a-3p	-7.72	2.35e-13	-0.58	-0.43	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026126	chr12:53991799~53991820:+
KIRP	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-7.72	2.42e-13	-0.62	-0.43	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-7.72	2.42e-13	-0.62	-0.43	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-7.63	4.35e-13	-0.63	-0.42	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
KIRP	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-7.5	9.43e-13	-0.66	-0.42	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
KIRP	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-7.5	9.58e-13	-0.61	-0.42	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
KIRP	cis	rs6841433	0.632	rs7699896	MIMAT0003242	hsa-miR-577	7.42	1.57e-12	0.55	0.42	Hemoglobin concentration;	chr4:114617357	chr4:114656774~114656794:+
KIRP	cis	rs754133	1	rs754133	MIMAT0004562	hsa-miR-196a-3p	-7.34	2.58e-12	-0.56	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54025136	chr12:53991799~53991820:+
KIRP	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	7.32	2.95e-12	0.53	0.41	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
KIRP	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-7.31	3.28e-12	-0.55	-0.41	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
KIRP	cis	rs754133	0.964	rs4759318	MIMAT0004562	hsa-miR-196a-3p	-7.3	3.35e-12	-0.55	-0.41	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026314	chr12:53991799~53991820:+
KIRP	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	7.27	3.96e-12	0.86	0.41	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
KIRP	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	7.24	4.89e-12	0.53	0.41	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	7.24	4.89e-12	0.53	0.41	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	7.24	4.89e-12	0.53	0.41	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	7.2	6.33e-12	0.53	0.41	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
KIRP	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-7.18	6.88e-12	-0.5	-0.4	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-7.18	6.98e-12	-0.5	-0.4	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
KIRP	cis	rs754133	0.964	rs894737	MIMAT0004562	hsa-miR-196a-3p	-7.16	7.79e-12	-0.55	-0.4	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54024359	chr12:53991799~53991820:+
KIRP	cis	rs754133	0.964	rs894738	MIMAT0004562	hsa-miR-196a-3p	-7.16	8.14e-12	-0.53	-0.4	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54023741	chr12:53991799~53991820:+
KIRP	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-7.15	8.48e-12	-0.51	-0.4	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
KIRP	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	7.15	8.69e-12	0.52	0.4	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	7.15	8.69e-12	0.52	0.4	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	7.15	8.69e-12	0.52	0.4	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	7.14	8.88e-12	0.52	0.4	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	7.14	8.88e-12	0.52	0.4	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	7.14	8.88e-12	0.52	0.4	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
KIRP	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-7.14	9e-12	-0.51	-0.4	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
KIRP	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	7.14	9.03e-12	0.52	0.4	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
KIRP	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	7.14	9.1e-12	0.52	0.4	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
KIRP	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-7.13	9.59e-12	-0.51	-0.4	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
KIRP	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	7.1	1.17e-11	0.52	0.4	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
KIRP	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-7.08	1.29e-11	-0.52	-0.4	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-7.08	1.3e-11	-0.52	-0.4	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
KIRP	cis	rs754133	0.963	rs12319419	MIMAT0004562	hsa-miR-196a-3p	-7.06	1.47e-11	-0.54	-0.4	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54026992	chr12:53991799~53991820:+
KIRP	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-7.03	1.78e-11	-0.5	-0.4	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	6.93	3.14e-11	0.51	0.39	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.632	rs4585328	MIMAT0003242	hsa-miR-577	-6.89	4.07e-11	-0.5	-0.39	Hemoglobin concentration;	chr4:114613660	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-6.87	4.53e-11	-0.62	-0.39	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-6.87	4.53e-11	-0.62	-0.39	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.632	rs7685523	MIMAT0003242	hsa-miR-577	-6.86	4.78e-11	-0.49	-0.39	Hemoglobin concentration;	chr4:114621913	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-6.85	5.06e-11	-0.6	-0.39	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-6.85	5.06e-11	-0.6	-0.39	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-6.84	5.45e-11	-0.5	-0.39	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-6.62	2.05e-10	-0.51	-0.38	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.503	rs4425400	MIMAT0003242	hsa-miR-577	-6.35	9.16e-10	-0.47	-0.36	Hemoglobin concentration;	chr4:114613788	chr4:114656774~114656794:+
KIRP	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	6.28	1.36e-09	0.57	0.36	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
KIRP	cis	rs11614913	0.509	rs12300425	MIMAT0004562	hsa-miR-196a-3p	-6.22	1.89e-09	-0.43	-0.36	Waist circumference adjusted for body mass index;	chr12:54001298	chr12:53991799~53991820:+
KIRP	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	6.22	1.95e-09	0.56	0.36	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
KIRP	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-6.12	3.41e-09	-0.48	-0.35	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.07	4.47e-09	-0.44	-0.35	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
KIRP	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-5.69	3.4e-08	-0.29	-0.33	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.809	rs35733223	MIMAT0003242	hsa-miR-577	5.65	4.19e-08	0.4	0.33	Optic disc area;	chr4:114566454	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-5.63	4.66e-08	-0.29	-0.33	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.63	4.68e-08	-0.29	-0.33	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-5.63	4.69e-08	-0.28	-0.33	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-5.63	4.69e-08	-0.28	-0.33	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-5.63	4.69e-08	-0.28	-0.33	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-5.62	4.79e-08	-0.28	-0.33	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-5.62	4.97e-08	-0.28	-0.33	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-5.6	5.4e-08	-0.28	-0.33	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-5.6	5.4e-08	-0.28	-0.33	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
KIRP	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-5.59	5.76e-08	-0.61	-0.33	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
KIRP	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-5.57	6.25e-08	-0.28	-0.32	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-5.57	6.41e-08	-0.28	-0.32	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	5.56	6.5e-08	0.28	0.32	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.735	rs9995962	MIMAT0003242	hsa-miR-577	5.56	6.69e-08	0.39	0.32	Optic disc area;	chr4:114551671	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.72e-08	-0.28	-0.32	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-5.56	6.73e-08	-0.28	-0.32	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	5.56	6.73e-08	0.28	0.32	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.809	rs12650546	MIMAT0003242	hsa-miR-577	5.56	6.74e-08	0.39	0.32	Optic disc area;	chr4:114578518	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
KIRP	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-5.54	7.49e-08	-0.28	-0.32	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.867	rs12507591	MIMAT0003242	hsa-miR-577	5.52	8.21e-08	0.39	0.32	Optic disc area;	chr4:114574339	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-5.51	8.41e-08	-0.28	-0.32	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-5.51	8.41e-08	-0.28	-0.32	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.809	rs9884212	MIMAT0003242	hsa-miR-577	5.51	8.61e-08	0.39	0.32	Optic disc area;	chr4:114580888	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.744	rs2388976	MIMAT0003242	hsa-miR-577	5.51	8.61e-08	0.39	0.32	Optic disc area;	chr4:114581250	chr4:114656774~114656794:+
KIRP	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-5.49	9.38e-08	-0.6	-0.32	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
KIRP	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-5.45	1.17e-07	-0.63	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-5.45	1.17e-07	-0.63	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
KIRP	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-5.42	1.37e-07	-0.63	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-5.42	1.37e-07	-0.63	-0.32	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
KIRP	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-5.41	1.39e-07	-0.27	-0.32	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-5.4	1.47e-07	-0.27	-0.32	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
KIRP	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-5.37	1.73e-07	-0.57	-0.31	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	5.36	1.82e-07	0.56	0.31	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
KIRP	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-5.35	1.87e-07	-0.27	-0.31	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.756	rs28787070	MIMAT0003242	hsa-miR-577	-5.35	1.89e-07	-0.39	-0.31	Optic disc area;	chr4:114556918	chr4:114656774~114656794:+
KIRP	cis	rs754133	0.507	rs10876531	MIMAT0004562	hsa-miR-196a-3p	-5.35	1.95e-07	-0.41	-0.31	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI in non-smokers;	chr12:54049934	chr12:53991799~53991820:+
KIRP	cis	rs453301	0.624	rs2915251	MIMAT0019728	hsa-miR-4660	5.34	2.03e-07	0.38	0.31	Joint mobility (Beighton score);	chr8:9009901	chr8:9048453~9048475:+
KIRP	cis	rs6543140	0.964	rs6543144	MIMAT0019927	hsa-miR-4772-3p	-5.33	2.12e-07	-0.28	-0.31	Blood protein levels;	chr2:102476116	chr2:102432336~102432357:+
KIRP	cis	rs259842	0.699	rs56008592	MIMAT0005909	hsa-miR-1258	5.26	2.98e-07	0.34	0.31	Blood protein levels;	chr2:179864497	chr2:179860845~179860865:-
KIRP	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-5.26	3.02e-07	-0.21	-0.31	Migraine;	chr10:103286250	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-5.26	3.02e-07	-0.21	-0.31	Migraine;	chr10:103286932	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-5.25	3.09e-07	-0.21	-0.31	Migraine;	chr10:103369141	chr10:103394301~103394322:-
KIRP	cis	rs7829975	0.564	rs2976855	MIMAT0019728	hsa-miR-4660	5.23	3.54e-07	0.39	0.31	Mood instability;	chr8:8444284	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-5.21	3.88e-07	-0.21	-0.31	Migraine;	chr10:103365694	chr10:103394301~103394322:-
KIRP	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-5.2	4.09e-07	-0.56	-0.3	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
KIRP	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-5.18	4.49e-07	-0.21	-0.3	Migraine;	chr10:103394332	chr10:103394301~103394322:-
KIRP	cis	rs259842	0.584	rs7588510	MIMAT0005909	hsa-miR-1258	5.18	4.51e-07	0.37	0.3	Blood protein levels;	chr2:179867682	chr2:179860845~179860865:-
KIRP	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-5.17	4.64e-07	-0.21	-0.3	Migraine;	chr10:103315955	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-5.14	5.29e-07	-0.21	-0.3	Migraine;	chr10:103415374	chr10:103394301~103394322:-
KIRP	cis	rs259842	0.737	rs13411964	MIMAT0005909	hsa-miR-1258	5.13	5.68e-07	0.33	0.3	Blood protein levels;	chr2:179861799	chr2:179860845~179860865:-
KIRP	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-5.12	5.79e-07	-0.26	-0.3	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.597	rs11098263	MIMAT0003242	hsa-miR-577	-5.12	5.89e-07	-0.37	-0.3	Optic disc area;	chr4:114686481	chr4:114656774~114656794:+
KIRP	cis	rs259842	0.699	rs56291671	MIMAT0005909	hsa-miR-1258	5.12	5.92e-07	0.33	0.3	Blood protein levels;	chr2:179864165	chr2:179860845~179860865:-
KIRP	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-5.11	6.04e-07	-0.21	-0.3	Migraine;	chr10:103295206	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.756	rs35235288	MIMAT0003242	hsa-miR-577	-5.11	6.21e-07	-0.38	-0.3	Optic disc area;	chr4:114547620	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	5.1	6.5e-07	0.23	0.3	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.521	rs116635794	MIMAT0003242	hsa-miR-577	-5.08	7.2e-07	-0.37	-0.3	Optic disc area;	chr4:114520865	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs6839599	MIMAT0003242	hsa-miR-577	-5.08	7.27e-07	-0.36	-0.3	Optic disc area;	chr4:114494754	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	5.07	7.37e-07	0.23	0.3	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	5.07	7.48e-07	0.23	0.3	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	5.07	7.48e-07	0.23	0.3	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
KIRP	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	5.07	7.65e-07	0.21	0.3	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
KIRP	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-5.06	8.04e-07	-0.39	-0.3	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
KIRP	cis	rs10021731	0.718	rs2054305	MIMAT0003242	hsa-miR-577	-5.05	8.17e-07	-0.36	-0.3	Optic disc area;	chr4:114496175	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.624	rs2288671	MIMAT0019728	hsa-miR-4660	5.04	8.5e-07	0.36	0.3	Joint mobility (Beighton score);	chr8:9003384	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.663	rs10169684	MIMAT0005909	hsa-miR-1258	5.04	8.68e-07	0.33	0.3	Blood protein levels;	chr2:179864874	chr2:179860845~179860865:-
KIRP	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.03	9.21e-07	-0.3	-0.3	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs7655989	MIMAT0003242	hsa-miR-577	-5.02	9.4e-07	-0.36	-0.3	Optic disc area;	chr4:114528134	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs2199312	MIMAT0003242	hsa-miR-577	-5.02	9.44e-07	-0.36	-0.3	Optic disc area;	chr4:114513322	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.577	rs34941812	MIMAT0003242	hsa-miR-577	-5.02	9.54e-07	-0.36	-0.3	Optic disc area;	chr4:114673260	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs10028232	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114487644	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7671026	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114487736	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs10031142	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114488433	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs17678686	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114489100	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs28766989	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114489752	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs11722125	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114490374	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs11722162	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114490460	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs11722201	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114490577	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs1585448	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114491050	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1870655	MIMAT0003242	hsa-miR-577	-5.01	9.8e-07	-0.35	-0.29	Optic disc area;	chr4:114491625	chr4:114656774~114656794:+
KIRP	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	5.01	9.92e-07	0.21	0.29	Migraine;	chr10:103263177	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.718	rs2219591	MIMAT0003242	hsa-miR-577	-5.01	9.95e-07	-0.35	-0.29	Optic disc area;	chr4:114491902	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs2199310	MIMAT0003242	hsa-miR-577	-5.01	9.95e-07	-0.35	-0.29	Optic disc area;	chr4:114492246	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	5.01	9.97e-07	0.22	0.29	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs1585447	MIMAT0003242	hsa-miR-577	-5.01	1.01e-06	-0.35	-0.29	Optic disc area;	chr4:114490912	chr4:114656774~114656794:+
KIRP	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-5.01	1.01e-06	-0.2	-0.29	Migraine;	chr10:103338267	chr10:103394301~103394322:-
KIRP	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	5	1.03e-06	0.23	0.29	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
KIRP	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-5	1.03e-06	-0.21	-0.29	Migraine;	chr10:103254113	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.718	rs2035059	MIMAT0003242	hsa-miR-577	-5	1.07e-06	-0.35	-0.29	Optic disc area;	chr4:114496530	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs6840798	MIMAT0003242	hsa-miR-577	-4.99	1.09e-06	-0.36	-0.29	Optic disc area;	chr4:114495078	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs6817762	MIMAT0003242	hsa-miR-577	-4.99	1.09e-06	-0.36	-0.29	Optic disc area;	chr4:114495098	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs7690858	MIMAT0003242	hsa-miR-577	-4.99	1.1e-06	-0.35	-0.29	Optic disc area;	chr4:114511804	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs993460	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114510521	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.693	rs7686100	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114511670	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4295329	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114511945	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs4409027	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114511985	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4413472	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114512090	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs11936113	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114512224	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs11936150	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114512391	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs28361366	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114512809	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs28656197	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114512821	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs2199314	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114513555	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs28736894	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114514184	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs17622270	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114514205	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs958771	MIMAT0003242	hsa-miR-577	-4.99	1.12e-06	-0.35	-0.29	Optic disc area;	chr4:114514506	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	4.98	1.13e-06	0.22	0.29	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	4.98	1.13e-06	0.22	0.29	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	4.98	1.13e-06	0.22	0.29	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	4.98	1.13e-06	0.22	0.29	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.692	rs13147488	MIMAT0003242	hsa-miR-577	-4.98	1.14e-06	-0.36	-0.29	Optic disc area;	chr4:114494051	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1460771	MIMAT0003242	hsa-miR-577	4.98	1.15e-06	0.35	0.29	Optic disc area;	chr4:114486755	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs1599316	MIMAT0003242	hsa-miR-577	-4.97	1.22e-06	-0.35	-0.29	Optic disc area;	chr4:114490702	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs66482879	MIMAT0003242	hsa-miR-577	-4.96	1.24e-06	-0.35	-0.29	Optic disc area;	chr4:114517522	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs28657376	MIMAT0003242	hsa-miR-577	-4.96	1.24e-06	-0.35	-0.29	Optic disc area;	chr4:114517650	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs7684322	MIMAT0003242	hsa-miR-577	-4.96	1.24e-06	-0.35	-0.29	Optic disc area;	chr4:114519788	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs12108520	MIMAT0003242	hsa-miR-577	-4.96	1.24e-06	-0.35	-0.29	Optic disc area;	chr4:114522087	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13117126	MIMAT0003242	hsa-miR-577	-4.96	1.24e-06	-0.35	-0.29	Optic disc area;	chr4:114526758	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs7662125	MIMAT0003242	hsa-miR-577	-4.96	1.26e-06	-0.35	-0.29	Optic disc area;	chr4:114495706	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs2054303	MIMAT0003242	hsa-miR-577	-4.96	1.26e-06	-0.35	-0.29	Optic disc area;	chr4:114495803	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs13103833	MIMAT0003242	hsa-miR-577	-4.96	1.26e-06	-0.35	-0.29	Optic disc area;	chr4:114495414	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs10857032	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.35	-0.29	Optic disc area;	chr4:114527831	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.631	rs11098253	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.35	-0.29	Optic disc area;	chr4:114527990	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs12512563	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.36	-0.29	Optic disc area;	chr4:114493973	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.6	rs12504927	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.36	-0.29	Optic disc area;	chr4:114493975	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.645	rs13147121	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.36	-0.29	Optic disc area;	chr4:114493994	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13103158	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.35	-0.29	Optic disc area;	chr4:114493188	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs13127680	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.35	-0.29	Optic disc area;	chr4:114493217	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.693	rs4834415	MIMAT0003242	hsa-miR-577	-4.96	1.27e-06	-0.35	-0.29	Optic disc area;	chr4:114493245	chr4:114656774~114656794:+
KIRP	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	4.96	1.29e-06	0.2	0.29	Migraine;	chr10:103236031	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-4.96	1.29e-06	-0.2	-0.29	Migraine;	chr10:103296155	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.597	rs12508215	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.36	-0.29	Optic disc area;	chr4:114699103	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4833458	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.35	-0.29	Optic disc area;	chr4:114493571	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4833459	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.35	-0.29	Optic disc area;	chr4:114493734	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs12501292	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.35	-0.29	Optic disc area;	chr4:114493876	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.622	rs12711027	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.35	-0.29	Optic disc area;	chr4:114494204	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13148430	MIMAT0003242	hsa-miR-577	-4.95	1.31e-06	-0.35	-0.29	Optic disc area;	chr4:114494469	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-4.95	1.31e-06	-0.22	-0.29	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs13102706	MIMAT0003242	hsa-miR-577	-4.95	1.33e-06	-0.35	-0.29	Optic disc area;	chr4:114492998	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13102910	MIMAT0003242	hsa-miR-577	-4.95	1.33e-06	-0.35	-0.29	Optic disc area;	chr4:114493049	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13127839	MIMAT0003242	hsa-miR-577	-4.95	1.33e-06	-0.35	-0.29	Optic disc area;	chr4:114493059	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-4.94	1.39e-06	-0.29	-0.29	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.809	rs12647519	MIMAT0003242	hsa-miR-577	4.94	1.41e-06	0.36	0.29	Optic disc area;	chr4:114594742	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.645	rs7698524	MIMAT0003242	hsa-miR-577	-4.94	1.41e-06	-0.36	-0.29	Optic disc area;	chr4:114492417	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1460772	MIMAT0003242	hsa-miR-577	-4.93	1.42e-06	-0.35	-0.29	Optic disc area;	chr4:114487028	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs7698363	MIMAT0003242	hsa-miR-577	-4.93	1.43e-06	-0.36	-0.29	Optic disc area;	chr4:114492418	chr4:114656774~114656794:+
KIRP	cis	rs9394169	0.533	rs4713675	MIMAT0022975	hsa-miR-3934-3p	-4.93	1.45e-06	-0.34	-0.29	Essential tremor;	chr6:33750641	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.718	rs7689158	MIMAT0003242	hsa-miR-577	-4.93	1.47e-06	-0.35	-0.29	Optic disc area;	chr4:114495770	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs2054304	MIMAT0003242	hsa-miR-577	-4.93	1.48e-06	-0.35	-0.29	Optic disc area;	chr4:114495902	chr4:114656774~114656794:+
KIRP	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	4.92	1.5e-06	0.22	0.29	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
KIRP	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	4.92	1.5e-06	0.22	0.29	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs1585446	MIMAT0003242	hsa-miR-577	-4.92	1.51e-06	-0.35	-0.29	Optic disc area;	chr4:114490871	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.668	rs2199311	MIMAT0003242	hsa-miR-577	-4.92	1.55e-06	-0.35	-0.29	Optic disc area;	chr4:114492288	chr4:114656774~114656794:+
KIRP	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-4.9	1.7e-06	-0.23	-0.29	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs10857031	MIMAT0003242	hsa-miR-577	-4.89	1.73e-06	-0.35	-0.29	Optic disc area;	chr4:114527690	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs10021252	MIMAT0003242	hsa-miR-577	-4.89	1.77e-06	-0.35	-0.29	Optic disc area;	chr4:114515190	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs12108281	MIMAT0003242	hsa-miR-577	-4.89	1.77e-06	-0.35	-0.29	Optic disc area;	chr4:114522147	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs13105714	MIMAT0003242	hsa-miR-577	-4.88	1.8e-06	-0.35	-0.29	Optic disc area;	chr4:114511171	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs12505597	MIMAT0003242	hsa-miR-577	-4.88	1.83e-06	-0.35	-0.29	Optic disc area;	chr4:114527954	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs2054306	MIMAT0003242	hsa-miR-577	-4.88	1.84e-06	-0.35	-0.29	Optic disc area;	chr4:114496204	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.744	rs6814022	MIMAT0003242	hsa-miR-577	-4.88	1.86e-06	-0.35	-0.29	Optic disc area;	chr4:114528667	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.782	rs12650319	MIMAT0003242	hsa-miR-577	4.87	1.91e-06	0.35	0.29	Optic disc area;	chr4:114594734	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs6834235	MIMAT0003242	hsa-miR-577	-4.87	1.92e-06	-0.35	-0.29	Optic disc area;	chr4:114531582	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1599320	MIMAT0003242	hsa-miR-577	-4.87	1.92e-06	-0.35	-0.29	Optic disc area;	chr4:114532227	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs2126028	MIMAT0003242	hsa-miR-577	-4.87	1.92e-06	-0.35	-0.29	Optic disc area;	chr4:114533453	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.598	rs10104303	MIMAT0019728	hsa-miR-4660	4.86	1.99e-06	0.35	0.29	Joint mobility (Beighton score);	chr8:8977018	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.624	rs6987558	MIMAT0019728	hsa-miR-4660	4.86	2e-06	0.35	0.29	Joint mobility (Beighton score);	chr8:9005011	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.693	rs114243292	MIMAT0003242	hsa-miR-577	-4.85	2.09e-06	-0.35	-0.29	Optic disc area;	chr4:114516751	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13127822	MIMAT0003242	hsa-miR-577	-4.85	2.13e-06	-0.35	-0.29	Optic disc area;	chr4:114493024	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4409025	MIMAT0003242	hsa-miR-577	-4.85	2.13e-06	-0.35	-0.29	Optic disc area;	chr4:114511785	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs4409026	MIMAT0003242	hsa-miR-577	-4.85	2.13e-06	-0.35	-0.29	Optic disc area;	chr4:114511787	chr4:114656774~114656794:+
KIRP	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-4.84	2.22e-06	-0.29	-0.29	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
KIRP	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-4.84	2.25e-06	-0.29	-0.29	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.718	rs13104656	MIMAT0003242	hsa-miR-577	-4.83	2.29e-06	-0.35	-0.29	Optic disc area;	chr4:114495547	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs13104685	MIMAT0003242	hsa-miR-577	-4.83	2.29e-06	-0.35	-0.29	Optic disc area;	chr4:114495590	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs13104693	MIMAT0003242	hsa-miR-577	-4.83	2.29e-06	-0.35	-0.29	Optic disc area;	chr4:114495600	chr4:114656774~114656794:+
KIRP	cis	rs4713675	0.565	rs4713671	MIMAT0022975	hsa-miR-3934-3p	-4.83	2.3e-06	-0.32	-0.29	Plateletcrit;	chr6:33732122	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.718	rs7698790	MIMAT0003242	hsa-miR-577	4.82	2.42e-06	0.34	0.28	Optic disc area;	chr4:114492647	chr4:114656774~114656794:+
KIRP	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	4.81	2.57e-06	0.22	0.28	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
KIRP	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	4.79	2.76e-06	0.22	0.28	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.668	rs1599317	MIMAT0003242	hsa-miR-577	-4.78	2.85e-06	-0.34	-0.28	Optic disc area;	chr4:114503010	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs10516602	MIMAT0003242	hsa-miR-577	-4.78	2.91e-06	-0.34	-0.28	Optic disc area;	chr4:114486174	chr4:114656774~114656794:+
KIRP	cis	rs259842	0.612	rs10185471	MIMAT0005909	hsa-miR-1258	4.78	2.91e-06	0.31	0.28	Blood protein levels;	chr2:179844879	chr2:179860845~179860865:-
KIRP	cis	rs10021731	0.718	rs7686774	MIMAT0003242	hsa-miR-577	-4.76	3.2e-06	-0.34	-0.28	Optic disc area;	chr4:114480357	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.782	rs7437569	MIMAT0003242	hsa-miR-577	-4.76	3.21e-06	-0.34	-0.28	Optic disc area;	chr4:114595431	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7687413	MIMAT0003242	hsa-miR-577	-4.75	3.27e-06	-0.34	-0.28	Optic disc area;	chr4:114480417	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.644	rs7665675	MIMAT0003242	hsa-miR-577	-4.75	3.27e-06	-0.34	-0.28	Optic disc area;	chr4:114480704	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7692571	MIMAT0003242	hsa-miR-577	-4.75	3.27e-06	-0.34	-0.28	Optic disc area;	chr4:114480792	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs11724674	MIMAT0003242	hsa-miR-577	-4.75	3.27e-06	-0.34	-0.28	Optic disc area;	chr4:114482175	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs62309866	MIMAT0003242	hsa-miR-577	-4.74	3.5e-06	-0.34	-0.28	Optic disc area;	chr4:114479583	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7685549	MIMAT0003242	hsa-miR-577	-4.74	3.5e-06	-0.34	-0.28	Optic disc area;	chr4:114479772	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.782	rs2388975	MIMAT0003242	hsa-miR-577	4.73	3.68e-06	0.34	0.28	Optic disc area;	chr4:114592899	chr4:114656774~114656794:+
KIRP	cis	rs4713675	0.565	rs4711343	MIMAT0022975	hsa-miR-3934-3p	-4.71	3.99e-06	-0.32	-0.28	Plateletcrit;	chr6:33746771	chr6:33698191~33698212:+
KIRP	cis	rs189798	0.807	rs330905	MIMAT0019728	hsa-miR-4660	4.71	4e-06	0.38	0.28	Myopia (pathological);	chr8:9136041	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.565	rs4713674	MIMAT0022975	hsa-miR-3934-3p	4.71	4.02e-06	0.33	0.28	Plateletcrit;	chr6:33740392	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs60704560	MIMAT0022975	hsa-miR-3934-3p	-4.7	4.13e-06	-0.32	-0.28	Plateletcrit;	chr6:33745523	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.718	rs10002657	MIMAT0003242	hsa-miR-577	-4.7	4.22e-06	-0.34	-0.28	Optic disc area;	chr4:114483120	chr4:114656774~114656794:+
KIRP	cis	rs7829975	0.606	rs6422352	MIMAT0019728	hsa-miR-4660	-4.7	4.22e-06	-0.34	-0.28	Mood instability;	chr8:8936683	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.606	rs891570	MIMAT0019728	hsa-miR-4660	-4.7	4.22e-06	-0.34	-0.28	Mood instability;	chr8:8936944	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.718	rs11724670	MIMAT0003242	hsa-miR-577	-4.7	4.24e-06	-0.34	-0.28	Optic disc area;	chr4:114482122	chr4:114656774~114656794:+
KIRP	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	4.7	4.25e-06	0.22	0.28	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
KIRP	cis	rs453301	0.653	rs11784393	MIMAT0019728	hsa-miR-4660	4.69	4.33e-06	0.35	0.28	Joint mobility (Beighton score);	chr8:9045624	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.546	rs9348925	MIMAT0022975	hsa-miR-3934-3p	-4.69	4.45e-06	-0.32	-0.28	Plateletcrit;	chr6:33742919	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.546	rs12503437	MIMAT0003242	hsa-miR-577	-4.68	4.49e-06	-0.34	-0.28	Optic disc area;	chr4:114534955	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.546	rs12503481	MIMAT0003242	hsa-miR-577	-4.68	4.49e-06	-0.34	-0.28	Optic disc area;	chr4:114535080	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.653	rs1045529	MIMAT0019728	hsa-miR-4660	-4.67	4.79e-06	-0.35	-0.28	Joint mobility (Beighton score);	chr8:9032588	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.73	rs7815817	MIMAT0019728	hsa-miR-4660	4.67	4.84e-06	0.4	0.28	Multiple myeloma (hyperdiploidy);	chr8:9576201	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601336	MIMAT0019728	hsa-miR-4660	4.67	4.84e-06	0.4	0.28	Multiple myeloma (hyperdiploidy);	chr8:9576956	chr8:9048453~9048475:+
KIRP	cis	rs6993244	1	rs6993244	MIMAT0019728	hsa-miR-4660	4.65	5.16e-06	0.34	0.28	Mean corpuscular hemoglobin;	chr8:9005549	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.624	rs2979265	MIMAT0019728	hsa-miR-4660	4.64	5.57e-06	0.35	0.27	Joint mobility (Beighton score);	chr8:9001207	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.612	rs966440	MIMAT0005909	hsa-miR-1258	4.63	5.68e-06	0.31	0.27	Blood protein levels;	chr2:179838881	chr2:179860845~179860865:-
KIRP	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	4.63	5.7e-06	0.21	0.27	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
KIRP	cis	rs453301	0.653	rs2956244	MIMAT0019728	hsa-miR-4660	4.62	6.14e-06	0.35	0.27	Joint mobility (Beighton score);	chr8:9027656	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.612	rs10183495	MIMAT0005909	hsa-miR-1258	-4.61	6.14e-06	-0.31	-0.27	Blood protein levels;	chr2:179804450	chr2:179860845~179860865:-
KIRP	cis	rs10021731	0.546	rs7668023	MIMAT0003242	hsa-miR-577	-4.61	6.15e-06	-0.33	-0.27	Optic disc area;	chr4:114535366	chr4:114656774~114656794:+
KIRP	cis	rs259842	0.67	rs1352110	MIMAT0005909	hsa-miR-1258	4.61	6.23e-06	0.3	0.27	Blood protein levels;	chr2:179843791	chr2:179860845~179860865:-
KIRP	cis	rs259842	0.663	rs4894131	MIMAT0005909	hsa-miR-1258	4.61	6.35e-06	0.29	0.27	Blood protein levels;	chr2:179863333	chr2:179860845~179860865:-
KIRP	cis	rs7829975	0.606	rs10112585	MIMAT0019728	hsa-miR-4660	-4.6	6.57e-06	-0.33	-0.27	Mood instability;	chr8:8937520	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs4841212	MIMAT0019728	hsa-miR-4660	-4.6	6.64e-06	-0.39	-0.27	Mosquito bite size;	chr8:9743857	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.809	rs7655987	MIMAT0003242	hsa-miR-577	4.59	6.75e-06	0.33	0.27	Optic disc area;	chr4:114596146	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1824490	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114529766	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs1824489	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114529776	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7669767	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114530264	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs12508960	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114531061	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.681	rs11098254	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114531300	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs11098255	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114531393	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7683270	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114532438	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13103719	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114532620	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.681	rs13109008	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114532769	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13109803	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114532837	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs7440658	MIMAT0003242	hsa-miR-577	4.59	6.84e-06	0.33	0.27	Optic disc area;	chr4:114533303	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.718	rs13104081	MIMAT0003242	hsa-miR-577	-4.59	6.85e-06	-0.33	-0.27	Optic disc area;	chr4:114532641	chr4:114656774~114656794:+
KIRP	cis	rs4713675	0.565	rs9348924	MIMAT0022975	hsa-miR-3934-3p	-4.59	6.85e-06	-0.32	-0.27	Plateletcrit;	chr6:33737659	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs4711341	MIMAT0022975	hsa-miR-3934-3p	-4.59	6.99e-06	-0.31	-0.27	Plateletcrit;	chr6:33723020	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.718	rs2100782	MIMAT0003242	hsa-miR-577	4.58	7.06e-06	0.33	0.27	Optic disc area;	chr4:114530452	chr4:114656774~114656794:+
KIRP	cis	rs4713675	0.584	rs9394163	MIMAT0022975	hsa-miR-3934-3p	-4.58	7.08e-06	-0.31	-0.27	Plateletcrit;	chr6:33714637	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.525	rs4841239	MIMAT0019728	hsa-miR-4660	-4.58	7.08e-06	-0.41	-0.27	Multiple myeloma (hyperdiploidy);	chr8:9835315	chr8:9048453~9048475:+
KIRP	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-4.58	7.19e-06	-0.27	-0.27	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
KIRP	cis	rs12545912	0.82	rs6990590	MIMAT0019728	hsa-miR-4660	4.58	7.28e-06	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9564641	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.631	rs13250781	MIMAT0019728	hsa-miR-4660	-4.58	7.3e-06	-0.35	-0.27	Joint mobility (Beighton score);	chr8:8935833	chr8:9048453~9048475:+
KIRP	cis	rs4851551	0.867	rs3171845	MIMAT0019926	hsa-miR-4772-5p	4.58	7.32e-06	0.45	0.27	Blood protein levels;	chr2:102174921	chr2:102432300~102432321:+
KIRP	cis	rs4851551	0.867	rs3917330	MIMAT0019926	hsa-miR-4772-5p	4.58	7.32e-06	0.45	0.27	Blood protein levels;	chr2:102179965	chr2:102432300~102432321:+
KIRP	cis	rs4851551	0.867	rs3917331	MIMAT0019926	hsa-miR-4772-5p	4.58	7.32e-06	0.45	0.27	Blood protein levels;	chr2:102179966	chr2:102432300~102432321:+
KIRP	cis	rs12545912	0.774	rs28668310	MIMAT0019728	hsa-miR-4660	4.57	7.46e-06	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9562576	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs28622033	MIMAT0019728	hsa-miR-4660	4.57	7.46e-06	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9562703	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs2966	MIMAT0022975	hsa-miR-3934-3p	-4.56	7.85e-06	-0.31	-0.27	Plateletcrit;	chr6:33721743	chr6:33698191~33698212:+
KIRP	cis	rs453301	0.597	rs7001187	MIMAT0019728	hsa-miR-4660	-4.56	7.97e-06	-0.35	-0.27	Joint mobility (Beighton score);	chr8:8935272	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.565	rs4713670	MIMAT0022975	hsa-miR-3934-3p	4.55	8.04e-06	0.31	0.27	Plateletcrit;	chr6:33732105	chr6:33698191~33698212:+
KIRP	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-4.55	8.36e-06	-0.17	-0.27	Migraine;	chr10:103283532	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-4.55	8.36e-06	-0.17	-0.27	Migraine;	chr10:103284207	chr10:103394301~103394322:-
KIRP	cis	rs189798	0.807	rs330912	MIMAT0019728	hsa-miR-4660	4.54	8.52e-06	0.4	0.27	Myopia (pathological);	chr8:9138784	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.718	rs1460779	MIMAT0003242	hsa-miR-577	4.54	8.6e-06	0.33	0.27	Optic disc area;	chr4:114528894	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.509	rs7000323	MIMAT0019728	hsa-miR-4660	-4.53	9e-06	-0.34	-0.27	Joint mobility (Beighton score);	chr8:8934763	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.641	rs1486234	MIMAT0005909	hsa-miR-1258	4.53	9e-06	0.3	0.27	Blood protein levels;	chr2:179843015	chr2:179860845~179860865:-
KIRP	cis	rs330048	0.545	rs10503387	MIMAT0019728	hsa-miR-4660	4.53	9.03e-06	0.37	0.27	Systemic lupus erythematosus;	chr8:9293015	chr8:9048453~9048475:+
KIRP	cis	rs189798	0.738	rs330911	MIMAT0019728	hsa-miR-4660	4.53	9.09e-06	0.4	0.27	Myopia (pathological);	chr8:9138763	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs12543534	MIMAT0019728	hsa-miR-4660	4.53	9.09e-06	0.41	0.27	Multiple myeloma (hyperdiploidy);	chr8:9564846	chr8:9048453~9048475:+
KIRP	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-4.53	9.13e-06	-0.32	-0.27	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.774	rs12681719	MIMAT0019728	hsa-miR-4660	4.52	9.17e-06	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9566993	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.582	rs6982832	MIMAT0019728	hsa-miR-4660	-4.52	9.34e-06	-0.33	-0.27	Mood instability;	chr8:8934707	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.582	rs6983150	MIMAT0019728	hsa-miR-4660	-4.52	9.34e-06	-0.33	-0.27	Mood instability;	chr8:8934916	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	4.52	9.35e-06	0.24	0.27	Migraine;	chr10:103236031	chr10:103394341~103394361:-
KIRP	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-4.52	9.38e-06	-0.27	-0.27	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
KIRP	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-4.52	9.38e-06	-0.27	-0.27	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
KIRP	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-4.52	9.38e-06	-0.27	-0.27	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
KIRP	cis	rs4713675	0.584	rs3227	MIMAT0022975	hsa-miR-3934-3p	-4.52	9.47e-06	-0.3	-0.27	Plateletcrit;	chr6:33694518	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs749847	MIMAT0022975	hsa-miR-3934-3p	-4.52	9.47e-06	-0.3	-0.27	Plateletcrit;	chr6:33697224	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.82	rs4841174	MIMAT0019728	hsa-miR-4660	4.51	9.62e-06	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9579070	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs7814014	MIMAT0019728	hsa-miR-4660	4.51	9.62e-06	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9579411	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs7822548	MIMAT0019728	hsa-miR-4660	4.51	9.62e-06	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9580435	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.631	rs28572014	MIMAT0019728	hsa-miR-4660	-4.51	9.63e-06	-0.34	-0.27	Joint mobility (Beighton score);	chr8:8936097	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.509	rs7838674	MIMAT0019728	hsa-miR-4660	-4.51	9.86e-06	-0.33	-0.27	Mood instability;	chr8:8939563	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.653	rs1562211	MIMAT0019728	hsa-miR-4660	-4.5	1e-05	-0.34	-0.27	Joint mobility (Beighton score);	chr8:9044914	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.593	rs2921077	MIMAT0019728	hsa-miR-4660	4.5	1.01e-05	0.34	0.27	Mood instability;	chr8:8446992	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.513	rs17150237	MIMAT0019728	hsa-miR-4660	-4.5	1.02e-05	-0.4	-0.27	Multiple myeloma (hyperdiploidy);	chr8:9554209	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.585	rs7570985	MIMAT0005909	hsa-miR-1258	4.5	1.03e-05	0.29	0.27	Blood protein levels;	chr2:179804807	chr2:179860845~179860865:-
KIRP	cis	rs453301	0.592	rs4841084	MIMAT0019728	hsa-miR-4660	4.5	1.04e-05	0.34	0.27	Joint mobility (Beighton score);	chr8:9026395	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs10098758	MIMAT0019728	hsa-miR-4660	4.49	1.05e-05	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9567955	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs10087166	MIMAT0019728	hsa-miR-4660	4.49	1.05e-05	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9571836	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	4.49	1.07e-05	0.24	0.27	Migraine;	chr10:103263177	chr10:103394341~103394361:-
KIRP	cis	rs12545912	0.774	rs12548285	MIMAT0019728	hsa-miR-4660	4.49	1.08e-05	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9565038	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.612	rs7573137	MIMAT0005909	hsa-miR-1258	4.49	1.08e-05	0.29	0.27	Blood protein levels;	chr2:179801215	chr2:179860845~179860865:-
KIRP	cis	rs12545912	0.774	rs12548306	MIMAT0019728	hsa-miR-4660	4.48	1.13e-05	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9565046	chr8:9048453~9048475:+
KIRP	cis	rs4711336	0.935	rs754404	MIMAT0022975	hsa-miR-3934-3p	-4.47	1.14e-05	-0.3	-0.27	Height;	chr6:33696953	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.774	rs10101953	MIMAT0019728	hsa-miR-4660	4.47	1.14e-05	0.39	0.27	Multiple myeloma (hyperdiploidy);	chr8:9568329	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.585	rs4894130	MIMAT0005909	hsa-miR-1258	4.47	1.14e-05	0.31	0.27	Blood protein levels;	chr2:179851202	chr2:179860845~179860865:-
KIRP	cis	rs12545912	0.774	rs61551896	MIMAT0019728	hsa-miR-4660	4.47	1.15e-05	0.38	0.27	Multiple myeloma (hyperdiploidy);	chr8:9562185	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.51	rs332037	MIMAT0019728	hsa-miR-4660	4.47	1.16e-05	0.34	0.27	Mood instability;	chr8:8865165	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6986386	MIMAT0019728	hsa-miR-4660	4.47	1.17e-05	0.4	0.27	Multiple myeloma (hyperdiploidy);	chr8:9564279	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601332	MIMAT0019728	hsa-miR-4660	4.46	1.19e-05	0.38	0.26	Multiple myeloma (hyperdiploidy);	chr8:9561155	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs9380375	MIMAT0022975	hsa-miR-3934-3p	-4.46	1.2e-05	-0.3	-0.26	Plateletcrit;	chr6:33714614	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs942643	MIMAT0022975	hsa-miR-3934-3p	-4.46	1.21e-05	-0.3	-0.26	Plateletcrit;	chr6:33700593	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.774	rs12675511	MIMAT0019728	hsa-miR-4660	4.46	1.24e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9569113	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs67706102	MIMAT0019728	hsa-miR-4660	4.46	1.24e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9569182	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601333	MIMAT0019728	hsa-miR-4660	4.46	1.24e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9569538	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601335	MIMAT0019728	hsa-miR-4660	4.46	1.24e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9569638	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.73	rs58238328	MIMAT0019728	hsa-miR-4660	4.46	1.24e-05	0.38	0.26	Multiple myeloma (hyperdiploidy);	chr8:9562377	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.709	rs542441	MIMAT0022975	hsa-miR-3934-3p	4.45	1.24e-05	0.31	0.26	Plateletcrit;	chr6:33708074	chr6:33698191~33698212:+
KIRP	cis	rs453301	0.624	rs4841083	MIMAT0019728	hsa-miR-4660	4.45	1.24e-05	0.33	0.26	Joint mobility (Beighton score);	chr8:9012918	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.696	rs9329203	MIMAT0019728	hsa-miR-4660	-4.45	1.25e-05	-0.4	-0.26	Multiple myeloma (hyperdiploidy);	chr8:9554643	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.557	rs10205122	MIMAT0005909	hsa-miR-1258	4.45	1.27e-05	0.31	0.26	Blood protein levels;	chr2:179858504	chr2:179860845~179860865:-
KIRP	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-4.45	1.27e-05	-0.26	-0.26	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
KIRP	cis	rs453301	0.657	rs36056437	MIMAT0019728	hsa-miR-4660	-4.45	1.28e-05	-0.34	-0.26	Joint mobility (Beighton score);	chr8:8935355	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.546	rs10947435	MIMAT0022975	hsa-miR-3934-3p	-4.45	1.29e-05	-0.31	-0.26	Plateletcrit;	chr6:33750298	chr6:33698191~33698212:+
KIRP	cis	rs189798	0.592	rs10111263	MIMAT0019728	hsa-miR-4660	-4.44	1.31e-05	-0.34	-0.26	Myopia (pathological);	chr8:9111923	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.636	rs11612380	MIMAT0003287	hsa-miR-618	4.44	1.31e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81141526	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs35069036	MIMAT0003287	hsa-miR-618	4.44	1.31e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81141696	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs7960221	MIMAT0003287	hsa-miR-618	4.44	1.31e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81142041	chr12:80935796~80935818:-
KIRP	cis	rs4713675	0.584	rs6938056	MIMAT0022975	hsa-miR-3934-3p	-4.44	1.34e-05	-0.3	-0.26	Plateletcrit;	chr6:33701800	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs9394161	MIMAT0022975	hsa-miR-3934-3p	-4.44	1.34e-05	-0.3	-0.26	Plateletcrit;	chr6:33702016	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs7739505	MIMAT0022975	hsa-miR-3934-3p	-4.44	1.34e-05	-0.3	-0.26	Plateletcrit;	chr6:33702593	chr6:33698191~33698212:+
KIRP	cis	rs453301	0.624	rs2979256	MIMAT0019728	hsa-miR-4660	4.44	1.34e-05	0.33	0.26	Joint mobility (Beighton score);	chr8:9014200	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.653	rs7853	MIMAT0019728	hsa-miR-4660	4.44	1.34e-05	0.33	0.26	Joint mobility (Beighton score);	chr8:9033304	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs4713666	MIMAT0022975	hsa-miR-3934-3p	-4.43	1.36e-05	-0.3	-0.26	Plateletcrit;	chr6:33711284	chr6:33698191~33698212:+
KIRP	cis	rs10021731	1	rs11098258	MIMAT0003242	hsa-miR-577	4.43	1.37e-05	0.32	0.26	Optic disc area;	chr4:114564528	chr4:114656774~114656794:+
KIRP	cis	rs4713675	0.565	rs2274458	MIMAT0022975	hsa-miR-3934-3p	-4.43	1.4e-05	-0.3	-0.26	Plateletcrit;	chr6:33711819	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs942640	MIMAT0022975	hsa-miR-3934-3p	-4.43	1.4e-05	-0.3	-0.26	Plateletcrit;	chr6:33718665	chr6:33698191~33698212:+
KIRP	cis	rs330048	0.545	rs11774353	MIMAT0019728	hsa-miR-4660	4.43	1.4e-05	0.36	0.26	Systemic lupus erythematosus;	chr8:9295617	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	4.43	1.41e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
KIRP	cis	rs7829975	0.572	rs7005000	MIMAT0019728	hsa-miR-4660	-4.42	1.42e-05	-0.32	-0.26	Mood instability;	chr8:8939092	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.585	rs7607354	MIMAT0005909	hsa-miR-1258	4.42	1.45e-05	0.3	0.26	Blood protein levels;	chr2:179826215	chr2:179860845~179860865:-
KIRP	cis	rs453301	0.598	rs2921383	MIMAT0019728	hsa-miR-4660	4.42	1.47e-05	0.33	0.26	Joint mobility (Beighton score);	chr8:9034711	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.567	rs6601273	MIMAT0019728	hsa-miR-4660	-4.42	1.47e-05	-0.32	-0.26	Mood instability;	chr8:8939009	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.606	rs7819827	MIMAT0019728	hsa-miR-4660	-4.42	1.47e-05	-0.32	-0.26	Mood instability;	chr8:8939545	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.573	rs7842359	MIMAT0019728	hsa-miR-4660	-4.42	1.47e-05	-0.32	-0.26	Mood instability;	chr8:8939568	chr8:9048453~9048475:+
KIRP	cis	rs17639215	0.55	rs4851003	MIMAT0019927	hsa-miR-4772-3p	-4.41	1.48e-05	-0.23	-0.26	Serum protein levels (sST2);	chr2:102292817	chr2:102432336~102432357:+
KIRP	cis	rs259842	0.641	rs7603617	MIMAT0005909	hsa-miR-1258	4.41	1.48e-05	0.29	0.26	Blood protein levels;	chr2:179841775	chr2:179860845~179860865:-
KIRP	cis	rs10021731	0.729	rs17047190	MIMAT0003242	hsa-miR-577	4.41	1.49e-05	0.33	0.26	Optic disc area;	chr4:114536699	chr4:114656774~114656794:+
KIRP	cis	rs10492002	0.636	rs4306334	MIMAT0003287	hsa-miR-618	4.41	1.53e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81111304	chr12:80935796~80935818:-
KIRP	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-4.41	1.53e-05	-0.17	-0.26	Migraine;	chr10:103241568	chr10:103394301~103394322:-
KIRP	cis	rs4713675	0.524	rs4713672	MIMAT0022975	hsa-miR-3934-3p	-4.41	1.53e-05	-0.31	-0.26	Plateletcrit;	chr6:33737289	chr6:33698191~33698212:+
KIRP	cis	rs453301	0.631	rs17700611	MIMAT0019728	hsa-miR-4660	-4.41	1.53e-05	-0.34	-0.26	Joint mobility (Beighton score);	chr8:8936144	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.584	rs7601013	MIMAT0005909	hsa-miR-1258	4.41	1.54e-05	0.29	0.26	Blood protein levels;	chr2:179828310	chr2:179860845~179860865:-
KIRP	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-4.4	1.55e-05	-0.23	-0.26	Migraine;	chr10:103254113	chr10:103394341~103394361:-
KIRP	cis	rs12545912	0.73	rs10088969	MIMAT0019728	hsa-miR-4660	4.4	1.56e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9568188	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs11995920	MIMAT0019728	hsa-miR-4660	4.4	1.56e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9568471	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs11985349	MIMAT0019728	hsa-miR-4660	4.4	1.56e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9568649	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs12676898	MIMAT0019728	hsa-miR-4660	4.4	1.56e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9568904	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs12675476	MIMAT0019728	hsa-miR-4660	4.4	1.56e-05	0.4	0.26	Multiple myeloma (hyperdiploidy);	chr8:9568908	chr8:9048453~9048475:+
KIRP	cis	rs4851551	0.867	rs3917289	MIMAT0019926	hsa-miR-4772-5p	4.4	1.56e-05	0.44	0.26	Blood protein levels;	chr2:102165451	chr2:102432300~102432321:+
KIRP	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	4.4	1.57e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	4.4	1.57e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	4.4	1.57e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
KIRP	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	4.4	1.59e-05	0.17	0.26	Migraine;	chr10:103238157	chr10:103394301~103394322:-
KIRP	cis	rs7829975	0.617	rs4841071	MIMAT0019728	hsa-miR-4660	4.39	1.61e-05	0.33	0.26	Mood instability;	chr8:8933634	chr8:9048453~9048475:+
KIRP	cis	rs2921073	0.51	rs2976945	MIMAT0019728	hsa-miR-4660	4.39	1.61e-05	0.34	0.26	Parkinson's disease;	chr8:8413361	chr8:9048453~9048475:+
KIRP	cis	rs10021731	1	rs10021731	MIMAT0003242	hsa-miR-577	4.39	1.62e-05	0.32	0.26	Optic disc area;	chr4:114560759	chr4:114656774~114656794:+
KIRP	cis	rs4711336	0.935	rs3818529	MIMAT0022975	hsa-miR-3934-3p	-4.39	1.62e-05	-0.29	-0.26	Height;	chr6:33693329	chr6:33698191~33698212:+
KIRP	cis	rs7829975	0.659	rs4382480	MIMAT0019728	hsa-miR-4660	4.39	1.63e-05	0.32	0.26	Mood instability;	chr8:8863963	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.636	rs4584646	MIMAT0003287	hsa-miR-618	4.39	1.64e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81111382	chr12:80935796~80935818:-
KIRP	cis	rs4711336	0.935	rs3818525	MIMAT0022975	hsa-miR-3934-3p	-4.39	1.66e-05	-0.29	-0.26	Height;	chr6:33693002	chr6:33698191~33698212:+
KIRP	cis	rs259842	0.612	rs1480707	MIMAT0005909	hsa-miR-1258	4.38	1.68e-05	0.29	0.26	Blood protein levels;	chr2:179844751	chr2:179860845~179860865:-
KIRP	cis	rs6695223	1	rs4907132	MIMAT0019232	hsa-miR-4423-5p	-4.38	1.69e-05	-0.43	-0.26	Venous thromboembolism (SNP x SNP interaction);	chr1:85071839	chr1:85133806~85133827:+
KIRP	cis	rs259842	0.584	rs13388545	MIMAT0005909	hsa-miR-1258	4.38	1.7e-05	0.29	0.26	Blood protein levels;	chr2:179844467	chr2:179860845~179860865:-
KIRP	cis	rs330048	0.545	rs719409	MIMAT0019728	hsa-miR-4660	4.38	1.7e-05	0.36	0.26	Systemic lupus erythematosus;	chr8:9293716	chr8:9048453~9048475:+
KIRP	cis	rs9394169	0.592	rs4304152	MIMAT0022975	hsa-miR-3934-3p	-4.38	1.71e-05	-0.3	-0.26	Essential tremor;	chr6:33755513	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.709	rs626156	MIMAT0022975	hsa-miR-3934-3p	4.38	1.72e-05	0.3	0.26	Plateletcrit;	chr6:33702705	chr6:33698191~33698212:+
KIRP	cis	rs7829975	0.572	rs28730413	MIMAT0019728	hsa-miR-4660	-4.38	1.72e-05	-0.32	-0.26	Mood instability;	chr8:8937937	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.612	rs13399189	MIMAT0005909	hsa-miR-1258	4.38	1.75e-05	0.29	0.26	Blood protein levels;	chr2:179803485	chr2:179860845~179860865:-
KIRP	cis	rs4713675	0.584	rs9368776	MIMAT0022975	hsa-miR-3934-3p	-4.38	1.75e-05	-0.29	-0.26	Plateletcrit;	chr6:33728628	chr6:33698191~33698212:+
KIRP	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	4.37	1.76e-05	0.29	0.26	Asthma;	chr2:102344364	chr2:102432300~102432321:+
KIRP	cis	rs4713675	0.584	rs4711339	MIMAT0022975	hsa-miR-3934-3p	-4.37	1.79e-05	-0.3	-0.26	Plateletcrit;	chr6:33699422	chr6:33698191~33698212:+
KIRP	cis	rs10492002	0.558	rs11613490	MIMAT0003287	hsa-miR-618	4.37	1.81e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81145895	chr12:80935796~80935818:-
KIRP	cis	rs259842	0.584	rs1480706	MIMAT0005909	hsa-miR-1258	4.37	1.81e-05	0.29	0.26	Blood protein levels;	chr2:179844180	chr2:179860845~179860865:-
KIRP	cis	rs453301	0.653	rs7016139	MIMAT0019728	hsa-miR-4660	-4.37	1.82e-05	-0.32	-0.26	Joint mobility (Beighton score);	chr8:9037960	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	4.37	1.82e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
KIRP	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.36	1.83e-05	-0.27	-0.26	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
KIRP	cis	rs12545912	0.82	rs4128199	MIMAT0019728	hsa-miR-4660	4.36	1.85e-05	0.39	0.26	Multiple myeloma (hyperdiploidy);	chr8:9575831	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.565	rs9469566	MIMAT0022975	hsa-miR-3934-3p	-4.36	1.85e-05	-0.29	-0.26	Plateletcrit;	chr6:33699828	chr6:33698191~33698212:+
KIRP	cis	rs2055729	0.557	rs7000542	MIMAT0019728	hsa-miR-4660	4.36	1.85e-05	0.35	0.26	Multiple myeloma (hyperdiploidy);	chr8:10023625	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs57453266	MIMAT0019728	hsa-miR-4660	4.36	1.87e-05	0.39	0.26	Multiple myeloma (hyperdiploidy);	chr8:9572540	chr8:9048453~9048475:+
KIRP	cis	rs10021731	1	rs6533801	MIMAT0003242	hsa-miR-577	4.36	1.87e-05	0.32	0.26	Optic disc area;	chr4:114553199	chr4:114656774~114656794:+
KIRP	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	4.36	1.88e-05	0.23	0.26	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
KIRP	cis	rs10492002	0.636	rs17736448	MIMAT0003287	hsa-miR-618	4.35	1.91e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81116390	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs61934932	MIMAT0003287	hsa-miR-618	4.35	1.91e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81117248	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs7305347	MIMAT0003287	hsa-miR-618	4.35	1.91e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81119115	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs61934930	MIMAT0003287	hsa-miR-618	4.35	1.95e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81107027	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs11614891	MIMAT0003287	hsa-miR-618	4.35	1.95e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81107185	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs12817088	MIMAT0003287	hsa-miR-618	4.35	1.99e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81107848	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs35423806	MIMAT0003287	hsa-miR-618	4.35	1.99e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81110064	chr12:80935796~80935818:-
KIRP	cis	rs7829975	0.606	rs11776838	MIMAT0019728	hsa-miR-4660	-4.34	2e-05	-0.31	-0.26	Mood instability;	chr8:8937291	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601334	MIMAT0019728	hsa-miR-4660	4.34	2e-05	0.39	0.26	Multiple myeloma (hyperdiploidy);	chr8:9569545	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.596	rs34429601	MIMAT0003287	hsa-miR-618	4.34	2e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81105117	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs1574365	MIMAT0003287	hsa-miR-618	4.34	2e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81105515	chr12:80935796~80935818:-
KIRP	cis	rs259842	0.67	rs4894128	MIMAT0005909	hsa-miR-1258	4.34	2.01e-05	0.29	0.26	Blood protein levels;	chr2:179842583	chr2:179860845~179860865:-
KIRP	cis	rs259842	0.67	rs4894129	MIMAT0005909	hsa-miR-1258	4.34	2.01e-05	0.29	0.26	Blood protein levels;	chr2:179842692	chr2:179860845~179860865:-
KIRP	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-4.34	2.02e-05	-0.55	-0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
KIRP	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-4.34	2.02e-05	-0.55	-0.26	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
KIRP	cis	rs259842	0.612	rs10195952	MIMAT0005909	hsa-miR-1258	4.34	2.02e-05	0.29	0.26	Blood protein levels;	chr2:179850268	chr2:179860845~179860865:-
KIRP	cis	rs453301	0.631	rs11779804	MIMAT0019728	hsa-miR-4660	-4.34	2.03e-05	-0.33	-0.26	Joint mobility (Beighton score);	chr8:8940442	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.636	rs11610708	MIMAT0003287	hsa-miR-618	4.34	2.05e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81138869	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs36001372	MIMAT0003287	hsa-miR-618	4.34	2.06e-05	0.3	0.26	Response to antidepressant treatment (citalopram);	chr12:81146779	chr12:80935796~80935818:-
KIRP	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	4.34	2.06e-05	0.21	0.26	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
KIRP	cis	rs453301	0.686	rs13252797	MIMAT0019728	hsa-miR-4660	4.34	2.06e-05	0.31	0.26	Joint mobility (Beighton score);	chr8:9003920	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs12680578	MIMAT0019728	hsa-miR-4660	-4.34	2.06e-05	-0.36	-0.26	Mosquito bite size;	chr8:9741106	chr8:9048453~9048475:+
KIRP	cis	rs1163656	0.572	rs1402349	MIMAT0003287	hsa-miR-618	-4.34	2.07e-05	-0.31	-0.26	Dental caries;	chr12:80919985	chr12:80935796~80935818:-
KIRP	cis	rs10021731	0.83	rs28870381	MIMAT0003242	hsa-miR-577	4.33	2.08e-05	0.33	0.26	Optic disc area;	chr4:114557343	chr4:114656774~114656794:+
KIRP	cis	rs10492002	0.613	rs11114762	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81099128	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs10862238	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81100151	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs17736095	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81101115	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs12811480	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81101405	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs11608692	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81101897	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs11608718	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81102007	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.557	rs34246226	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81102245	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs2107416	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81138503	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs2107415	MIMAT0003287	hsa-miR-618	4.33	2.13e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81139299	chr12:80935796~80935818:-
KIRP	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-4.33	2.15e-05	-0.17	-0.26	Migraine;	chr10:103279822	chr10:103394301~103394322:-
KIRP	cis	rs10492002	0.636	rs34334790	MIMAT0003287	hsa-miR-618	4.32	2.19e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81122814	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs35713634	MIMAT0003287	hsa-miR-618	4.32	2.19e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81122818	chr12:80935796~80935818:-
KIRP	cis	rs4713675	0.51	rs1014933	MIMAT0022975	hsa-miR-3934-3p	-4.32	2.25e-05	-0.29	-0.26	Plateletcrit;	chr6:33709458	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs7770465	MIMAT0022975	hsa-miR-3934-3p	-4.32	2.25e-05	-0.29	-0.26	Plateletcrit;	chr6:33706379	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs4713661	MIMAT0022975	hsa-miR-3934-3p	-4.32	2.25e-05	-0.29	-0.26	Plateletcrit;	chr6:33706397	chr6:33698191~33698212:+
KIRP	cis	rs4711336	0.664	rs4713662	MIMAT0022975	hsa-miR-3934-3p	-4.32	2.25e-05	-0.29	-0.26	Height;	chr6:33706411	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.866	rs4841211	MIMAT0019728	hsa-miR-4660	-4.31	2.27e-05	-0.36	-0.26	Multiple myeloma (hyperdiploidy);	chr8:9742002	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.565	rs4713668	MIMAT0022975	hsa-miR-3934-3p	-4.31	2.27e-05	-0.29	-0.26	Plateletcrit;	chr6:33723019	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.546	rs10947434	MIMAT0022975	hsa-miR-3934-3p	-4.31	2.27e-05	-0.29	-0.26	Plateletcrit;	chr6:33723724	chr6:33698191~33698212:+
KIRP	cis	rs74233809	0.636	rs284851	MIMAT0022727	hsa-miR-1307-5p	-4.31	2.28e-05	-0.3	-0.26	Birth weight;	chr10:102818774	chr10:103394341~103394361:-
KIRP	cis	rs4713675	0.584	rs4713667	MIMAT0022975	hsa-miR-3934-3p	-4.31	2.29e-05	-0.3	-0.26	Plateletcrit;	chr6:33712239	chr6:33698191~33698212:+
KIRP	cis	rs10492002	0.597	rs12815528	MIMAT0003287	hsa-miR-618	4.31	2.32e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81126418	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs10492006	MIMAT0003287	hsa-miR-618	4.31	2.32e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81126959	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.596	rs73149275	MIMAT0003287	hsa-miR-618	4.31	2.32e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81128275	chr12:80935796~80935818:-
KIRP	cis	rs453301	0.631	rs7843369	MIMAT0019728	hsa-miR-4660	-4.31	2.32e-05	-0.33	-0.26	Joint mobility (Beighton score);	chr8:8940276	chr8:9048453~9048475:+
KIRP	cis	rs10021731	1	rs4834419	MIMAT0003242	hsa-miR-577	4.31	2.32e-05	0.32	0.26	Optic disc area;	chr4:114548870	chr4:114656774~114656794:+
KIRP	cis	rs10021731	1	rs1599323	MIMAT0003242	hsa-miR-577	4.31	2.32e-05	0.32	0.26	Optic disc area;	chr4:114549176	chr4:114656774~114656794:+
KIRP	cis	rs189798	0.807	rs12785	MIMAT0019728	hsa-miR-4660	4.31	2.33e-05	0.36	0.26	Myopia (pathological);	chr8:9137426	chr8:9048453~9048475:+
KIRP	cis	rs2048656	0.501	rs4510870	MIMAT0019728	hsa-miR-4660	-4.3	2.36e-05	-0.36	-0.26	Schizophrenia;	chr8:9622906	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs7846140	MIMAT0019728	hsa-miR-4660	4.3	2.36e-05	0.38	0.26	Multiple myeloma (hyperdiploidy);	chr8:9561009	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	4.3	2.36e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
KIRP	cis	rs453301	0.658	rs9329175	MIMAT0019728	hsa-miR-4660	-4.3	2.39e-05	-0.31	-0.26	Joint mobility (Beighton score);	chr8:9009151	chr8:9048453~9048475:+
KIRP	cis	rs74233809	0.591	rs284853	MIMAT0022727	hsa-miR-1307-5p	4.3	2.4e-05	0.3	0.26	Birth weight;	chr10:102814885	chr10:103394341~103394361:-
KIRP	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	4.3	2.4e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	4.3	2.4e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	4.3	2.4e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	4.3	2.4e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
KIRP	cis	rs10492002	0.558	rs11613491	MIMAT0003287	hsa-miR-618	4.29	2.46e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81145901	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.636	rs11614641	MIMAT0003287	hsa-miR-618	4.29	2.48e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81119546	chr12:80935796~80935818:-
KIRP	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	4.29	2.49e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
KIRP	cis	rs10492002	0.596	rs55924813	MIMAT0003287	hsa-miR-618	4.29	2.5e-05	0.29	0.26	Response to antidepressant treatment (citalopram);	chr12:81133017	chr12:80935796~80935818:-
KIRP	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	4.29	2.53e-05	0.2	0.26	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
KIRP	cis	rs7829975	0.572	rs28446104	MIMAT0019728	hsa-miR-4660	-4.29	2.54e-05	-0.31	-0.26	Mood instability;	chr8:8938391	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs6601331	MIMAT0019728	hsa-miR-4660	4.29	2.55e-05	0.37	0.26	Multiple myeloma (hyperdiploidy);	chr8:9560073	chr8:9048453~9048475:+
KIRP	cis	rs74233809	0.636	rs284861	MIMAT0022727	hsa-miR-1307-5p	4.28	2.57e-05	0.3	0.25	Birth weight;	chr10:102812519	chr10:103394341~103394361:-
KIRP	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	4.28	2.58e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
KIRP	cis	rs10021731	0.83	rs12648883	MIMAT0003242	hsa-miR-577	-4.28	2.59e-05	-0.33	-0.25	Optic disc area;	chr4:114576504	chr4:114656774~114656794:+
KIRP	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-4.28	2.59e-05	-0.16	-0.25	Migraine;	chr10:103273871	chr10:103394301~103394322:-
KIRP	cis	rs4713675	0.565	rs1555965	MIMAT0022975	hsa-miR-3934-3p	-4.28	2.6e-05	-0.29	-0.25	Plateletcrit;	chr6:33709623	chr6:33698191~33698212:+
KIRP	cis	rs10021731	0.83	rs28734840	MIMAT0003242	hsa-miR-577	4.28	2.61e-05	0.32	0.25	Optic disc area;	chr4:114575934	chr4:114656774~114656794:+
KIRP	cis	rs10492002	0.636	rs1435968	MIMAT0003287	hsa-miR-618	4.28	2.64e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81136877	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.547	rs7980266	MIMAT0003287	hsa-miR-618	4.28	2.65e-05	0.29	0.25	Response to antidepressant treatment (citalopram);	chr12:81137967	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.909	rs7461376	MIMAT0019728	hsa-miR-4660	-4.28	2.65e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9735959	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.789	rs56369100	MIMAT0019728	hsa-miR-4660	-4.28	2.65e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9736097	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11249942	MIMAT0019728	hsa-miR-4660	-4.28	2.65e-05	-0.35	-0.25	Mosquito bite size;	chr8:9736239	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.538	rs7830804	MIMAT0019728	hsa-miR-4660	-4.28	2.66e-05	-0.33	-0.25	Joint mobility (Beighton score);	chr8:9113252	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.631	rs11780774	MIMAT0019728	hsa-miR-4660	-4.27	2.67e-05	-0.33	-0.25	Joint mobility (Beighton score);	chr8:8941601	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-4.27	2.73e-05	-0.22	-0.25	Migraine;	chr10:103394332	chr10:103394341~103394361:-
KIRP	cis	rs4427176	0.507	rs7462054	MIMAT0019728	hsa-miR-4660	-4.27	2.74e-05	-0.36	-0.25	Mosquito bite size;	chr8:9721003	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.606	rs7837026	MIMAT0019728	hsa-miR-4660	-4.27	2.74e-05	-0.33	-0.25	Mood instability;	chr8:8944182	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.542	rs7844374	MIMAT0019728	hsa-miR-4660	-4.26	2.9e-05	-0.32	-0.25	Mood instability;	chr8:8941174	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.605	rs12546178	MIMAT0019728	hsa-miR-4660	-4.26	2.9e-05	-0.37	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9832581	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs4841175	MIMAT0019728	hsa-miR-4660	4.25	2.91e-05	0.37	0.25	Multiple myeloma (hyperdiploidy);	chr8:9579100	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs7834823	MIMAT0019728	hsa-miR-4660	4.25	2.91e-05	0.37	0.25	Multiple myeloma (hyperdiploidy);	chr8:9579842	chr8:9048453~9048475:+
KIRP	cis	rs7826238	0.653	rs2979202	MIMAT0019728	hsa-miR-4660	4.25	2.91e-05	0.32	0.25	Systolic blood pressure;	chr8:8486617	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.593	rs2979241	MIMAT0019728	hsa-miR-4660	4.25	2.99e-05	0.32	0.25	Mood instability;	chr8:8445843	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.691	rs7585592	MIMAT0005909	hsa-miR-1258	4.25	3e-05	0.28	0.25	Blood protein levels;	chr2:179801138	chr2:179860845~179860865:-
KIRP	cis	rs4713675	0.584	rs509539	MIMAT0022975	hsa-miR-3934-3p	4.24	3.03e-05	0.29	0.25	Plateletcrit;	chr6:33740413	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.774	rs10111980	MIMAT0019728	hsa-miR-4660	-4.24	3.06e-05	-0.37	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9560657	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs6457739	MIMAT0022975	hsa-miR-3934-3p	-4.24	3.07e-05	-0.28	-0.25	Plateletcrit;	chr6:33706054	chr6:33698191~33698212:+
KIRP	cis	rs6695223	0.929	rs2165076	MIMAT0019232	hsa-miR-4423-5p	-4.24	3.08e-05	-0.43	-0.25	Venous thromboembolism (SNP x SNP interaction);	chr1:85069369	chr1:85133806~85133827:+
KIRP	cis	rs7829975	0.626	rs907183	MIMAT0019728	hsa-miR-4660	-4.24	3.11e-05	-0.31	-0.25	Mood instability;	chr8:8872251	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs13249683	MIMAT0019728	hsa-miR-4660	-4.23	3.2e-05	-0.35	-0.25	Mosquito bite size;	chr8:9745028	chr8:9048453~9048475:+
KIRP	cis	rs4711336	0.527	rs28651968	MIMAT0022975	hsa-miR-3934-3p	-4.23	3.22e-05	-0.29	-0.25	Height;	chr6:33749647	chr6:33698191~33698212:+
KIRP	cis	rs1712517	0.838	rs1891293	MIMAT0005951	hsa-miR-1307-3p	4.23	3.23e-05	0.16	0.25	Migraine;	chr10:103242040	chr10:103394301~103394322:-
KIRP	cis	rs12545912	0.774	rs62493868	MIMAT0019728	hsa-miR-4660	4.23	3.24e-05	0.37	0.25	Multiple myeloma (hyperdiploidy);	chr8:9558838	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs6916949	MIMAT0022975	hsa-miR-3934-3p	-4.23	3.24e-05	-0.29	-0.25	Plateletcrit;	chr6:33710513	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs6917140	MIMAT0022975	hsa-miR-3934-3p	-4.23	3.24e-05	-0.29	-0.25	Plateletcrit;	chr6:33710617	chr6:33698191~33698212:+
KIRP	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	4.23	3.28e-05	0.2	0.25	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
KIRP	cis	rs259842	0.641	rs16867014	MIMAT0005909	hsa-miR-1258	-4.22	3.3e-05	-0.28	-0.25	Blood protein levels;	chr2:179809420	chr2:179860845~179860865:-
KIRP	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	4.22	3.31e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	4.22	3.31e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	4.22	3.31e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	4.22	3.31e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
KIRP	cis	rs4713675	0.604	rs791902	MIMAT0022975	hsa-miR-3934-3p	4.22	3.32e-05	0.3	0.25	Plateletcrit;	chr6:33734840	chr6:33698191~33698212:+
KIRP	cis	rs7829975	0.511	rs2976902	MIMAT0019728	hsa-miR-4660	4.22	3.38e-05	0.32	0.25	Mood instability;	chr8:8483595	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.908	rs10465002	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9724707	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs4841202	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9725193	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs4841206	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9726117	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs10464998	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9726940	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.866	rs10903318	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9727973	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs4305907	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9728958	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11785927	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9730230	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11783635	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Mosquito bite size;	chr8:9730293	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs11779335	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9730344	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.866	rs4626603	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9730597	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.866	rs4626604	MIMAT0019728	hsa-miR-4660	-4.22	3.39e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9730602	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.756	rs1460782	MIMAT0003242	hsa-miR-577	-4.22	3.42e-05	-0.31	-0.25	Optic disc area;	chr4:114540002	chr4:114656774~114656794:+
KIRP	cis	rs7829975	0.511	rs2955578	MIMAT0019728	hsa-miR-4660	4.21	3.44e-05	0.34	0.25	Mood instability;	chr8:8279561	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs7462055	MIMAT0019728	hsa-miR-4660	-4.21	3.47e-05	-0.35	-0.25	Mosquito bite size;	chr8:9721021	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.598	rs1025395	MIMAT0019728	hsa-miR-4660	4.21	3.49e-05	0.31	0.25	Joint mobility (Beighton score);	chr8:8979093	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.67	rs13399303	MIMAT0005909	hsa-miR-1258	-4.21	3.52e-05	-0.28	-0.25	Blood protein levels;	chr2:179803574	chr2:179860845~179860865:-
KIRP	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	4.21	3.53e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
KIRP	cis	rs4713675	0.565	rs4713659	MIMAT0022975	hsa-miR-3934-3p	-4.21	3.55e-05	-0.28	-0.25	Plateletcrit;	chr6:33700062	chr6:33698191~33698212:+
KIRP	cis	rs2921073	0.51	rs2976944	MIMAT0019728	hsa-miR-4660	4.21	3.58e-05	0.33	0.25	Parkinson's disease;	chr8:8413404	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.612	rs13407401	MIMAT0005909	hsa-miR-1258	4.21	3.58e-05	0.28	0.25	Blood protein levels;	chr2:179850979	chr2:179860845~179860865:-
KIRP	cis	rs12545912	0.909	rs12674762	MIMAT0019728	hsa-miR-4660	-4.2	3.61e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9626616	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs12675893	MIMAT0019728	hsa-miR-4660	-4.2	3.61e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9621950	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs12680098	MIMAT0019728	hsa-miR-4660	-4.2	3.61e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9622030	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs12682247	MIMAT0019728	hsa-miR-4660	-4.2	3.61e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9622089	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	4.2	3.62e-05	0.16	0.25	Migraine;	chr10:103367830	chr10:103394301~103394322:-
KIRP	cis	rs12545912	0.821	rs1055328	MIMAT0019728	hsa-miR-4660	-4.2	3.63e-05	-0.37	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9781806	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.514	rs2920983	MIMAT0019728	hsa-miR-4660	4.2	3.66e-05	0.33	0.25	Mood instability;	chr8:8410553	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.858	rs259844	MIMAT0005909	hsa-miR-1258	4.2	3.68e-05	0.27	0.25	Blood protein levels;	chr2:179871061	chr2:179860845~179860865:-
KIRP	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	4.2	3.68e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	4.2	3.68e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
KIRP	cis	rs259842	0.612	rs1351416	MIMAT0005909	hsa-miR-1258	4.2	3.7e-05	0.28	0.25	Blood protein levels;	chr2:179843621	chr2:179860845~179860865:-
KIRP	cis	rs4713675	0.565	rs4711340	MIMAT0022975	hsa-miR-3934-3p	-4.2	3.71e-05	-0.28	-0.25	Plateletcrit;	chr6:33713354	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs9368773	MIMAT0022975	hsa-miR-3934-3p	-4.2	3.71e-05	-0.28	-0.25	Plateletcrit;	chr6:33714764	chr6:33698191~33698212:+
KIRP	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-4.2	3.72e-05	-0.25	-0.25	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
KIRP	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-4.19	3.74e-05	-0.16	-0.25	Migraine;	chr10:103299082	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-4.19	3.74e-05	-0.22	-0.25	Migraine;	chr10:103286250	chr10:103394341~103394361:-
KIRP	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-4.19	3.74e-05	-0.22	-0.25	Migraine;	chr10:103286932	chr10:103394341~103394361:-
KIRP	cis	rs6695223	1	rs4907130	MIMAT0019232	hsa-miR-4423-5p	-4.19	3.76e-05	-0.42	-0.25	Venous thromboembolism (SNP x SNP interaction);	chr1:85071196	chr1:85133806~85133827:+
KIRP	cis	rs1355223	0.583	rs2915177	MIMAT0019776	hsa-miR-1343-3p	4.19	3.8e-05	0.31	0.25	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34858719	chr11:34941888~34941909:+
KIRP	cis	rs7829975	0.606	rs6601274	MIMAT0019728	hsa-miR-4660	-4.19	3.8e-05	-0.32	-0.25	Mood instability;	chr8:8941549	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	4.19	3.81e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
KIRP	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	4.19	3.81e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
KIRP	cis	rs10021731	1	rs13104222	MIMAT0003242	hsa-miR-577	4.19	3.82e-05	0.32	0.25	Optic disc area;	chr4:114549757	chr4:114656774~114656794:+
KIRP	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	4.19	3.85e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
KIRP	cis	rs7829975	0.617	rs4841072	MIMAT0019728	hsa-miR-4660	-4.19	3.88e-05	-0.3	-0.25	Mood instability;	chr8:8933743	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs4840428	MIMAT0019728	hsa-miR-4660	4.18	3.91e-05	0.36	0.25	Multiple myeloma (hyperdiploidy);	chr8:9578376	chr8:9048453~9048475:+
KIRP	cis	rs189798	0.738	rs330908	MIMAT0019728	hsa-miR-4660	4.18	3.92e-05	0.33	0.25	Myopia (pathological);	chr8:9137656	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-4.18	3.93e-05	-0.16	-0.25	Migraine;	chr10:103348698	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-4.18	3.93e-05	-0.16	-0.25	Migraine;	chr10:103353944	chr10:103394301~103394322:-
KIRP	cis	rs12545912	0.774	rs66516712	MIMAT0019728	hsa-miR-4660	4.18	3.96e-05	0.36	0.25	Multiple myeloma (hyperdiploidy);	chr8:9559025	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.793	rs12650568	MIMAT0003242	hsa-miR-577	4.18	3.99e-05	0.32	0.25	Optic disc area;	chr4:114578461	chr4:114656774~114656794:+
KIRP	cis	rs4427176	0.507	rs13276965	MIMAT0019728	hsa-miR-4660	-4.18	3.99e-05	-0.35	-0.25	Mosquito bite size;	chr8:9721742	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.668	rs13112732	MIMAT0003242	hsa-miR-577	-4.18	4e-05	-0.31	-0.25	Optic disc area;	chr4:114483845	chr4:114656774~114656794:+
KIRP	cis	rs10492002	0.557	rs7973522	MIMAT0003287	hsa-miR-618	4.18	4.01e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81095362	chr12:80935796~80935818:-
KIRP	cis	rs4713675	0.565	rs9366828	MIMAT0022975	hsa-miR-3934-3p	-4.18	4.01e-05	-0.28	-0.25	Plateletcrit;	chr6:33705021	chr6:33698191~33698212:+
KIRP	cis	rs943466	0.537	rs2296329	MIMAT0022975	hsa-miR-3934-3p	-4.18	4.02e-05	-0.38	-0.25	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;	chr6:33682966	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.82	rs6989126	MIMAT0019728	hsa-miR-4660	4.17	4.1e-05	0.36	0.25	Multiple myeloma (hyperdiploidy);	chr8:9576879	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-4.17	4.11e-05	-0.16	-0.25	Migraine;	chr10:103379204	chr10:103394301~103394322:-
KIRP	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-4.17	4.14e-05	-0.3	-0.25	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.82	rs10087012	MIMAT0019728	hsa-miR-4660	4.17	4.16e-05	0.37	0.25	Multiple myeloma (hyperdiploidy);	chr8:9571698	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.859	rs259843	MIMAT0005909	hsa-miR-1258	4.17	4.16e-05	0.26	0.25	Blood protein levels;	chr2:179871781	chr2:179860845~179860865:-
KIRP	cis	rs12545912	0.909	rs6987698	MIMAT0019728	hsa-miR-4660	-4.17	4.2e-05	-0.35	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9627184	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs13271097	MIMAT0019728	hsa-miR-4660	-4.16	4.27e-05	-0.37	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9554057	chr8:9048453~9048475:+
KIRP	cis	rs7477	0.557	rs9944524	MIMAT0005942	hsa-miR-1288-3p	4.16	4.29e-05	0.29	0.25	Amyotrophic lateral sclerosis;	chr17:16309336	chr17:16282058~16282078:+
KIRP	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-4.16	4.3e-05	-0.16	-0.25	Migraine;	chr10:103356299	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-4.16	4.3e-05	-0.16	-0.25	Migraine;	chr10:103358705	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-4.16	4.3e-05	-0.16	-0.25	Migraine;	chr10:103358719	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	4.16	4.35e-05	0.15	0.25	Migraine;	chr10:103248169	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	4.16	4.35e-05	0.15	0.25	Migraine;	chr10:103249329	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.756	rs1460783	MIMAT0003242	hsa-miR-577	-4.16	4.37e-05	-0.31	-0.25	Optic disc area;	chr4:114540109	chr4:114656774~114656794:+
KIRP	cis	rs1163656	0.605	rs7487519	MIMAT0003287	hsa-miR-618	-4.16	4.39e-05	-0.3	-0.25	Dental caries;	chr12:80921469	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.517	rs10110146	MIMAT0019728	hsa-miR-4660	-4.15	4.43e-05	-0.34	-0.25	Multiple myeloma (hyperdiploidy);	chr8:9827852	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4282575	MIMAT0019728	hsa-miR-4660	4.15	4.46e-05	0.35	0.25	Multiple myeloma (hyperdiploidy);	chr8:9608355	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs4841173	MIMAT0019728	hsa-miR-4660	4.15	4.52e-05	0.35	0.25	Multiple myeloma (hyperdiploidy);	chr8:9578546	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.511	rs2976906	MIMAT0019728	hsa-miR-4660	4.15	4.53e-05	0.31	0.25	Mood instability;	chr8:8484905	chr8:9048453~9048475:+
KIRP	cis	rs7477	0.557	rs4792728	MIMAT0005942	hsa-miR-1288-3p	4.14	4.6e-05	0.29	0.25	Amyotrophic lateral sclerosis;	chr17:16283501	chr17:16282058~16282078:+
KIRP	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-4.14	4.61e-05	-0.54	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
KIRP	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-4.14	4.61e-05	-0.54	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
KIRP	cis	rs10492002	1	rs12815742	MIMAT0003287	hsa-miR-618	4.14	4.62e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81150100	chr12:80935796~80935818:-
KIRP	cis	rs7477	0.557	rs9914734	MIMAT0005942	hsa-miR-1288-3p	4.14	4.65e-05	0.29	0.25	Amyotrophic lateral sclerosis;	chr17:16278700	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.82	rs6601337	MIMAT0019728	hsa-miR-4660	4.14	4.66e-05	0.35	0.25	Multiple myeloma (hyperdiploidy);	chr8:9577443	chr8:9048453~9048475:+
KIRP	cis	rs7477	0.557	rs2109262	MIMAT0005942	hsa-miR-1288-3p	4.14	4.67e-05	0.29	0.25	Amyotrophic lateral sclerosis;	chr17:16281315	chr17:16282058~16282078:+
KIRP	cis	rs7829975	0.582	rs448231	MIMAT0019728	hsa-miR-4660	-4.14	4.69e-05	-0.3	-0.25	Mood instability;	chr8:8932549	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs7759668	MIMAT0022975	hsa-miR-3934-3p	4.14	4.7e-05	0.3	0.25	Plateletcrit;	chr6:33702629	chr6:33698191~33698212:+
KIRP	cis	rs7477	0.557	rs6502498	MIMAT0005942	hsa-miR-1288-3p	4.14	4.75e-05	0.29	0.25	Amyotrophic lateral sclerosis;	chr17:16295661	chr17:16282058~16282078:+
KIRP	cis	rs10021731	0.798	rs34581144	MIMAT0003242	hsa-miR-577	4.14	4.76e-05	0.32	0.25	Optic disc area;	chr4:114583571	chr4:114656774~114656794:+
KIRP	cis	rs9693857	0.553	rs10100760	MIMAT0019728	hsa-miR-4660	-4.13	4.78e-05	-0.3	-0.25	Systolic blood pressure;	chr8:9513049	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.653	rs7005133	MIMAT0019728	hsa-miR-4660	4.13	4.85e-05	0.31	0.25	Joint mobility (Beighton score);	chr8:9043712	chr8:9048453~9048475:+
KIRP	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-4.13	4.87e-05	-0.3	-0.25	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-4.13	4.87e-05	-0.3	-0.25	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
KIRP	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-4.13	4.87e-05	-0.3	-0.25	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
KIRP	cis	rs4427176	0.507	rs7822904	MIMAT0019728	hsa-miR-4660	-4.13	4.9e-05	-0.36	-0.25	Mosquito bite size;	chr8:9677485	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	4.13	4.97e-05	0.2	0.25	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
KIRP	cis	rs7829975	0.514	rs2979139	MIMAT0019728	hsa-miR-4660	4.12	4.98e-05	0.32	0.25	Mood instability;	chr8:8410803	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.83	rs17622401	MIMAT0003242	hsa-miR-577	4.12	4.99e-05	0.32	0.25	Optic disc area;	chr4:114571551	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.83	rs4834421	MIMAT0003242	hsa-miR-577	4.12	4.99e-05	0.32	0.25	Optic disc area;	chr4:114572686	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.605	rs7843024	MIMAT0019728	hsa-miR-4660	-4.12	5e-05	-0.32	-0.25	Joint mobility (Beighton score);	chr8:8942466	chr8:9048453~9048475:+
KIRP	cis	rs330048	0.545	rs11781008	MIMAT0019728	hsa-miR-4660	4.12	5e-05	0.34	0.25	Systemic lupus erythematosus;	chr8:9295729	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	4.12	5.05e-05	0.19	0.25	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
KIRP	cis	rs10492002	0.636	rs1545083	MIMAT0003287	hsa-miR-618	4.12	5.07e-05	0.27	0.25	Response to antidepressant treatment (citalopram);	chr12:81133424	chr12:80935796~80935818:-
KIRP	cis	rs4378999	0.557	rs4267675	MIMAT0019957	hsa-miR-4787-3p	-4.12	5.11e-05	-0.45	-0.25	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in non-smokers;	chr3:51110376	chr3:50675130~50675153:+
KIRP	cis	rs10021731	0.668	rs7676684	MIMAT0003242	hsa-miR-577	4.12	5.14e-05	0.31	0.25	Optic disc area;	chr4:114492371	chr4:114656774~114656794:+
KIRP	cis	rs10492002	0.522	rs12315512	MIMAT0003287	hsa-miR-618	4.11	5.19e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81100600	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.522	rs12315517	MIMAT0003287	hsa-miR-618	4.11	5.19e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81100625	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.522	rs10862240	MIMAT0003287	hsa-miR-618	4.11	5.19e-05	0.28	0.25	Response to antidepressant treatment (citalopram);	chr12:81101847	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.522	rs11114765	MIMAT0003287	hsa-miR-618	-4.11	5.19e-05	-0.28	-0.25	Response to antidepressant treatment (citalopram);	chr12:81100495	chr12:80935796~80935818:-
KIRP	cis	rs7826238	0.594	rs2948285	MIMAT0019728	hsa-miR-4660	4.11	5.23e-05	0.33	0.25	Systolic blood pressure;	chr8:8273016	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-4.11	5.23e-05	-0.21	-0.25	Migraine;	chr10:103369141	chr10:103394341~103394361:-
KIRP	cis	rs12545912	0.909	rs4310210	MIMAT0019728	hsa-miR-4660	4.11	5.29e-05	0.35	0.25	Multiple myeloma (hyperdiploidy);	chr8:9609224	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs11994420	MIMAT0019728	hsa-miR-4660	4.11	5.29e-05	0.35	0.25	Multiple myeloma (hyperdiploidy);	chr8:9609791	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs7465249	MIMAT0019728	hsa-miR-4660	-4.11	5.32e-05	-0.34	-0.25	Mosquito bite size;	chr8:9720883	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs7462115	MIMAT0019728	hsa-miR-4660	-4.11	5.32e-05	-0.34	-0.25	Mosquito bite size;	chr8:9721165	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-4.11	5.34e-05	-0.38	-0.25	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
KIRP	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-4.11	5.34e-05	-0.21	-0.25	Migraine;	chr10:103315955	chr10:103394341~103394361:-
KIRP	cis	rs4790312	0.513	rs9912609	MIMAT0000426	hsa-miR-132-3p	4.11	5.36e-05	0.28	0.25	Left atrial antero-posterior diameter;	chr17:2064326	chr17:2049929~2049950:-
KIRP	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-4.1	5.4e-05	-0.16	-0.24	Migraine;	chr10:103367951	chr10:103394301~103394322:-
KIRP	cis	rs453301	0.631	rs7843789	MIMAT0019728	hsa-miR-4660	-4.1	5.43e-05	-0.32	-0.24	Joint mobility (Beighton score);	chr8:8943051	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-4.1	5.44e-05	-0.21	-0.24	Migraine;	chr10:103365694	chr10:103394341~103394361:-
KIRP	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-4.1	5.49e-05	-0.16	-0.24	Migraine;	chr10:103384531	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-4.1	5.49e-05	-0.16	-0.24	Migraine;	chr10:103386935	chr10:103394301~103394322:-
KIRP	cis	rs10021731	0.668	rs28651771	MIMAT0003242	hsa-miR-577	-4.1	5.53e-05	-0.3	-0.24	Optic disc area;	chr4:114501291	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.692	rs62309904	MIMAT0003242	hsa-miR-577	-4.1	5.53e-05	-0.3	-0.24	Optic disc area;	chr4:114514011	chr4:114656774~114656794:+
KIRP	cis	rs7477	0.529	rs11656811	MIMAT0005942	hsa-miR-1288-3p	4.1	5.6e-05	0.29	0.24	Amyotrophic lateral sclerosis;	chr17:16310940	chr17:16282058~16282078:+
KIRP	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-4.1	5.62e-05	-0.16	-0.24	Migraine;	chr10:103367521	chr10:103394301~103394322:-
KIRP	cis	rs7829975	0.633	rs2979181	MIMAT0019728	hsa-miR-4660	4.09	5.64e-05	0.32	0.24	Mood instability;	chr8:8465578	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.514	rs2945873	MIMAT0019728	hsa-miR-4660	4.09	5.66e-05	0.32	0.24	Mood instability;	chr8:8402935	chr8:9048453~9048475:+
KIRP	cis	rs1355223	0.583	rs2956074	MIMAT0019776	hsa-miR-1343-3p	4.09	5.67e-05	0.31	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34843333	chr11:34941888~34941909:+
KIRP	cis	rs189798	0.807	rs330909	MIMAT0019728	hsa-miR-4660	4.09	5.68e-05	0.34	0.24	Myopia (pathological);	chr8:9137877	chr8:9048453~9048475:+
KIRP	cis	rs56406844	0.51	rs12364489	MIMAT0004593	hsa-miR-130a-5p	-4.09	5.68e-05	-0.53	-0.24	Stem cell factor levels;	chr11:57561993	chr11:57641212~57641233:+
KIRP	cis	rs12545912	0.696	rs34206126	MIMAT0019728	hsa-miR-4660	4.09	5.71e-05	0.36	0.24	Multiple myeloma (hyperdiploidy);	chr8:9556727	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	4.09	5.79e-05	0.15	0.24	Migraine;	chr10:103261506	chr10:103394301~103394322:-
KIRP	cis	rs4713675	0.565	rs4713665	MIMAT0022975	hsa-miR-3934-3p	-4.09	5.81e-05	-0.28	-0.24	Plateletcrit;	chr6:33706642	chr6:33698191~33698212:+
KIRP	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.81e-05	-0.2	-0.24	Migraine;	chr10:103273985	chr10:103394341~103394361:-
KIRP	cis	rs1355223	0.583	rs2915178	MIMAT0019776	hsa-miR-1343-3p	4.08	5.88e-05	0.31	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34856504	chr11:34941888~34941909:+
KIRP	cis	rs6695223	1	rs4907131	MIMAT0019232	hsa-miR-4423-5p	4.08	5.89e-05	0.42	0.24	Venous thromboembolism (SNP x SNP interaction);	chr1:85071819	chr1:85133806~85133827:+
KIRP	cis	rs4427176	0.507	rs6601361	MIMAT0019728	hsa-miR-4660	-4.08	5.93e-05	-0.34	-0.24	Mosquito bite size;	chr8:9722233	chr8:9048453~9048475:+
KIRP	cis	rs4711336	0.664	rs4713663	MIMAT0022975	hsa-miR-3934-3p	-4.08	5.94e-05	-0.28	-0.24	Height;	chr6:33706420	chr6:33698191~33698212:+
KIRP	cis	rs4711336	0.638	rs4713664	MIMAT0022975	hsa-miR-3934-3p	-4.08	5.94e-05	-0.28	-0.24	Height;	chr6:33706421	chr6:33698191~33698212:+
KIRP	cis	rs4427176	0.507	rs7016561	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Mosquito bite size;	chr8:9722983	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.863	rs7015787	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9723202	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs7015963	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Mosquito bite size;	chr8:9723344	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.908	rs35159871	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9723424	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs7006785	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Mosquito bite size;	chr8:9723460	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs6983608	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Mosquito bite size;	chr8:9723817	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.908	rs6983762	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9723890	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs12676827	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9723922	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11989409	MIMAT0019728	hsa-miR-4660	-4.08	5.95e-05	-0.34	-0.24	Mosquito bite size;	chr8:9724256	chr8:9048453~9048475:+
KIRP	cis	rs7477	0.557	rs12939078	MIMAT0005942	hsa-miR-1288-3p	4.08	5.98e-05	0.29	0.24	Amyotrophic lateral sclerosis;	chr17:16313152	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.866	rs11984585	MIMAT0019728	hsa-miR-4660	4.08	6.01e-05	0.37	0.24	Multiple myeloma (hyperdiploidy);	chr8:9571178	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.866	rs11872032	MIMAT0005942	hsa-miR-1288-3p	4.08	6.03e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16094459	chr17:16282058~16282078:+
KIRP	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-4.08	6.06e-05	-0.34	-0.24	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
KIRP	cis	rs7210990	0.866	rs7207889	MIMAT0005942	hsa-miR-1288-3p	4.08	6.08e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16101054	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.909	rs4841182	MIMAT0019728	hsa-miR-4660	4.08	6.08e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9613204	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.821	rs4841183	MIMAT0019728	hsa-miR-4660	4.08	6.08e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9613352	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11785987	MIMAT0019728	hsa-miR-4660	-4.07	6.11e-05	-0.34	-0.24	Mosquito bite size;	chr8:9730384	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.908	rs7016839	MIMAT0019728	hsa-miR-4660	-4.07	6.11e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9730439	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.631	rs4840376	MIMAT0019728	hsa-miR-4660	-4.07	6.14e-05	-0.31	-0.24	Joint mobility (Beighton score);	chr8:8944591	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.628	rs6533791	MIMAT0003242	hsa-miR-577	-4.07	6.22e-05	-0.3	-0.24	Optic disc area;	chr4:114491869	chr4:114656774~114656794:+
KIRP	cis	rs6058526	0.631	rs6119230	MIMAT0015077	hsa-miR-3193	4.07	6.23e-05	0.31	0.24	Chronic obstructive pulmonary disease;	chr20:32262171	chr20:31607186~31607207:+
KIRP	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-4.07	6.28e-05	-0.21	-0.24	Migraine;	chr10:103415374	chr10:103394341~103394361:-
KIRP	cis	rs12545912	0.909	rs28695930	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9606228	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.865	rs55917145	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9606761	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs11993506	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9606910	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs10103752	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9607265	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs10088401	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9607291	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs6651495	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9607859	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs6651496	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9607981	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs6651501	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9608022	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs6651502	MIMAT0019728	hsa-miR-4660	4.07	6.28e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9608036	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-4.07	6.29e-05	-0.21	-0.24	Migraine;	chr10:103295206	chr10:103394341~103394361:-
KIRP	cis	rs10492002	0.8	rs7311803	MIMAT0003287	hsa-miR-618	4.07	6.3e-05	0.26	0.24	Response to antidepressant treatment (citalopram);	chr12:81152414	chr12:80935796~80935818:-
KIRP	cis	rs2274459	0.556	rs35250767	MIMAT0022975	hsa-miR-3934-3p	4.06	6.37e-05	0.32	0.24	Obesity (extreme);	chr6:33718063	chr6:33698191~33698212:+
KIRP	cis	rs2624839	0.704	rs13067082	MIMAT0019957	hsa-miR-4787-3p	-4.06	6.4e-05	-0.31	-0.24	Intelligence (multi-trait analysis);	chr3:50184282	chr3:50675130~50675153:+
KIRP	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.06	6.52e-05	-0.25	-0.24	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
KIRP	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.06	6.52e-05	-0.25	-0.24	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
KIRP	cis	rs7210990	0.83	rs178806	MIMAT0005942	hsa-miR-1288-3p	4.05	6.63e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16197297	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.831	rs178809	MIMAT0005942	hsa-miR-1288-3p	4.05	6.65e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16196459	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs178805	MIMAT0005942	hsa-miR-1288-3p	4.05	6.65e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16197814	chr17:16282058~16282078:+
KIRP	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.74e-05	-0.24	-0.24	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
KIRP	cis	rs4713675	0.565	rs3818530	MIMAT0022975	hsa-miR-3934-3p	-4.05	6.74e-05	-0.27	-0.24	Plateletcrit;	chr6:33693445	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.584	rs3818527	MIMAT0022975	hsa-miR-3934-3p	4.05	6.75e-05	0.28	0.24	Plateletcrit;	chr6:33693258	chr6:33698191~33698212:+
KIRP	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	4.05	6.77e-05	0.2	0.24	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
KIRP	cis	rs7826238	0.564	rs2921053	MIMAT0019728	hsa-miR-4660	4.05	6.77e-05	0.3	0.24	Systolic blood pressure;	chr8:8462453	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs10102030	MIMAT0019728	hsa-miR-4660	4.05	6.79e-05	0.35	0.24	Multiple myeloma (hyperdiploidy);	chr8:9572103	chr8:9048453~9048475:+
KIRP	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	4.05	6.79e-05	0.26	0.24	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
KIRP	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-4.05	6.8e-05	-0.25	-0.24	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
KIRP	cis	rs6695223	1	rs4243775	MIMAT0019232	hsa-miR-4423-5p	-4.04	6.89e-05	-0.41	-0.24	Venous thromboembolism (SNP x SNP interaction);	chr1:85071598	chr1:85133806~85133827:+
KIRP	cis	rs259842	0.67	rs13398994	MIMAT0005909	hsa-miR-1258	4.04	6.91e-05	0.26	0.24	Blood protein levels;	chr2:179803346	chr2:179860845~179860865:-
KIRP	cis	rs7982677	1	rs4085673	MIMAT0004491	hsa-miR-19b-1-5p	4.04	6.95e-05	0.26	0.24	Tetralogy of Fallot;	chr13:92306897	chr13:91351207~91351229:+
KIRP	cis	rs453301	0.579	rs10096850	MIMAT0019728	hsa-miR-4660	-4.04	6.99e-05	-0.31	-0.24	Joint mobility (Beighton score);	chr8:8940712	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	4.04	7.01e-05	0.15	0.24	Migraine;	chr10:103244344	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	4.04	7.08e-05	0.19	0.24	Migraine;	chr10:103242040	chr10:103394341~103394361:-
KIRP	cis	rs10021731	0.83	rs1460785	MIMAT0003242	hsa-miR-577	4.03	7.17e-05	0.31	0.24	Optic disc area;	chr4:114545757	chr4:114656774~114656794:+
KIRP	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-4.03	7.18e-05	-0.21	-0.24	Migraine;	chr10:103296155	chr10:103394341~103394361:-
KIRP	cis	rs2048656	0.535	rs2014514	MIMAT0019728	hsa-miR-4660	4.03	7.2e-05	0.31	0.24	Schizophrenia;	chr8:9789686	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.965	rs7016732	MIMAT0019728	hsa-miR-4660	-4.03	7.2e-05	-0.31	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9539717	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.818	rs7462102	MIMAT0019728	hsa-miR-4660	4.03	7.24e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9603858	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.83	rs1460784	MIMAT0003242	hsa-miR-577	4.03	7.35e-05	0.31	0.24	Optic disc area;	chr4:114541947	chr4:114656774~114656794:+
KIRP	cis	rs7210990	0.836	rs12947205	MIMAT0005942	hsa-miR-1288-3p	4.03	7.38e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16090013	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.557	rs11654658	MIMAT0005942	hsa-miR-1288-3p	-4.03	7.45e-05	-0.28	-0.24	Amyotrophic lateral sclerosis;	chr17:16304141	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.909	rs10903314	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9609596	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4568626	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9610322	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4464970	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9611192	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4418340	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9611481	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs6996976	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9611602	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs28716261	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9611694	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4398920	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9612066	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs28561748	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9612673	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs12335063	MIMAT0019728	hsa-miR-4660	4.02	7.45e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9612806	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.679	rs2624835	MIMAT0019957	hsa-miR-4787-3p	4.02	7.46e-05	0.31	0.24	Intelligence (multi-trait analysis);	chr3:50171616	chr3:50675130~50675153:+
KIRP	cis	rs9329221	0.655	rs656319	MIMAT0019728	hsa-miR-4660	-4.02	7.51e-05	-0.3	-0.24	Neuroticism;	chr8:9956901	chr8:9048453~9048475:+
KIRP	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-4.02	7.6e-05	-0.24	-0.24	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
KIRP	cis	rs6601327	0.571	rs7820675	MIMAT0019728	hsa-miR-4660	4.02	7.62e-05	0.31	0.24	Multiple myeloma (hyperdiploidy);	chr8:9790238	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.79	rs2170240	MIMAT0005909	hsa-miR-1258	4.02	7.63e-05	0.26	0.24	Blood protein levels;	chr2:179860583	chr2:179860845~179860865:-
KIRP	cis	rs7210990	0.8	rs2041460	MIMAT0005942	hsa-miR-1288-3p	4.02	7.69e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16003598	chr17:16282058~16282078:+
KIRP	cis	rs453301	0.564	rs28649568	MIMAT0019728	hsa-miR-4660	-4.01	7.79e-05	-0.3	-0.24	Joint mobility (Beighton score);	chr8:9102161	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.505	rs13418648	MIMAT0005909	hsa-miR-1258	4.01	7.81e-05	0.27	0.24	Blood protein levels;	chr2:179819475	chr2:179860845~179860865:-
KIRP	cis	rs9394169	0.514	rs1886355	MIMAT0022975	hsa-miR-3934-3p	-4.01	7.84e-05	-0.28	-0.24	Essential tremor;	chr6:33809100	chr6:33698191~33698212:+
KIRP	cis	rs7210990	0.68	rs178801	MIMAT0005942	hsa-miR-1288-3p	4.01	7.85e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16205150	chr17:16282058~16282078:+
KIRP	cis	rs2048656	0.501	rs13276750	MIMAT0019728	hsa-miR-4660	-4.01	7.9e-05	-0.34	-0.24	Schizophrenia;	chr8:9616699	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs11249931	MIMAT0019728	hsa-miR-4660	-4.01	7.9e-05	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9617789	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs13269437	MIMAT0019728	hsa-miR-4660	-4.01	7.92e-05	-0.34	-0.24	Mosquito bite size;	chr8:9721780	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.514	rs2920991	MIMAT0019728	hsa-miR-4660	4.01	7.97e-05	0.31	0.24	Mood instability;	chr8:8401607	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.565	rs2281829	MIMAT0022975	hsa-miR-3934-3p	-4.01	7.97e-05	-0.27	-0.24	Plateletcrit;	chr6:33707865	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.565	rs6904816	MIMAT0022975	hsa-miR-3934-3p	-4.01	7.97e-05	-0.27	-0.24	Plateletcrit;	chr6:33708379	chr6:33698191~33698212:+
KIRP	cis	rs9217	1	rs55749333	MIMAT0000761	hsa-miR-324-5p	4.01	7.99e-05	0.17	0.24	Height;	chr17:7468613	chr17:7223343~7223364:-
KIRP	cis	rs10492002	0.522	rs1882258	MIMAT0003287	hsa-miR-618	4.01	8.01e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81104925	chr12:80935796~80935818:-
KIRP	cis	rs4713675	0.565	rs6928010	MIMAT0022975	hsa-miR-3934-3p	-4	8.17e-05	-0.27	-0.24	Plateletcrit;	chr6:33708813	chr6:33698191~33698212:+
KIRP	cis	rs7210990	0.866	rs1989856	MIMAT0005942	hsa-miR-1288-3p	4	8.17e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16140337	chr17:16282058~16282078:+
KIRP	cis	rs7829975	0.626	rs332040	MIMAT0019728	hsa-miR-4660	4	8.19e-05	0.3	0.24	Mood instability;	chr8:8872978	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.545	rs12299448	MIMAT0003287	hsa-miR-618	4	8.2e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81102693	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.522	rs10862241	MIMAT0003287	hsa-miR-618	4	8.2e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81102979	chr12:80935796~80935818:-
KIRP	cis	rs10492002	0.522	rs12809234	MIMAT0003287	hsa-miR-618	4	8.22e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81103740	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.909	rs13262577	MIMAT0019728	hsa-miR-4660	-4	8.33e-05	-0.33	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9620253	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-4	8.35e-05	-0.15	-0.24	Migraine;	chr10:103262005	chr10:103394301~103394322:-
KIRP	cis	rs2048656	0.501	rs7464185	MIMAT0019728	hsa-miR-4660	3.99	8.42e-05	0.33	0.24	Schizophrenia;	chr8:9603485	chr8:9048453~9048475:+
KIRP	cis	rs2048656	0.501	rs7464226	MIMAT0019728	hsa-miR-4660	3.99	8.42e-05	0.33	0.24	Schizophrenia;	chr8:9603583	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-3.99	8.47e-05	-0.15	-0.24	Migraine;	chr10:103289348	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-3.99	8.47e-05	-0.15	-0.24	Migraine;	chr10:103292867	chr10:103394301~103394322:-
KIRP	cis	rs10492002	0.597	rs7306808	MIMAT0003287	hsa-miR-618	3.99	8.49e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81107695	chr12:80935796~80935818:-
KIRP	cis	rs7210990	0.8	rs2041459	MIMAT0005942	hsa-miR-1288-3p	3.99	8.52e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16003332	chr17:16282058~16282078:+
KIRP	cis	rs10492002	0.506	rs7297387	MIMAT0003287	hsa-miR-618	3.99	8.54e-05	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81108854	chr12:80935796~80935818:-
KIRP	cis	rs10859871	1	rs10859871	MIMAT0000760	hsa-miR-331-3p	-3.99	8.57e-05	-0.17	-0.24	Endometriosis;	chr12:95318100	chr12:95308480~95308500:+
KIRP	cis	rs10859871	1	rs4762173	MIMAT0000760	hsa-miR-331-3p	-3.99	8.57e-05	-0.17	-0.24	Endometriosis;	chr12:95318919	chr12:95308480~95308500:+
KIRP	cis	rs12545912	0.909	rs4840431	MIMAT0019728	hsa-miR-4660	3.99	8.66e-05	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9613338	chr8:9048453~9048475:+
KIRP	cis	rs4711336	1	rs4711336	MIMAT0022975	hsa-miR-3934-3p	3.99	8.71e-05	0.27	0.24	Height;	chr6:33691269	chr6:33698191~33698212:+
KIRP	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	3.98	8.75e-05	0.24	0.24	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
KIRP	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.86e-05	-0.21	-0.24	Migraine;	chr10:103338267	chr10:103394341~103394361:-
KIRP	cis	rs7829975	0.511	rs2921028	MIMAT0019728	hsa-miR-4660	3.98	8.89e-05	0.3	0.24	Mood instability;	chr8:8482967	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.836	rs1126148	MIMAT0005942	hsa-miR-1288-3p	3.98	8.92e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16112265	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.831	rs35622628	MIMAT0005942	hsa-miR-1288-3p	3.98	8.92e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16116714	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs12150017	MIMAT0005942	hsa-miR-1288-3p	3.98	8.92e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16120780	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.831	rs11078332	MIMAT0005942	hsa-miR-1288-3p	3.98	8.92e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16122754	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs11650678	MIMAT0005942	hsa-miR-1288-3p	3.98	8.92e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16124713	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.909	rs7815525	MIMAT0019728	hsa-miR-4660	3.98	8.93e-05	0.36	0.24	Multiple myeloma (hyperdiploidy);	chr8:9606093	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.836	rs3815038	MIMAT0005942	hsa-miR-1288-3p	3.98	8.96e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16065235	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs11655773	MIMAT0005942	hsa-miR-1288-3p	3.98	8.97e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16126985	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs1160109	MIMAT0005942	hsa-miR-1288-3p	3.98	8.97e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16129818	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs9891646	MIMAT0005942	hsa-miR-1288-3p	3.98	8.97e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16133547	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.764	rs9907313	MIMAT0005942	hsa-miR-1288-3p	3.98	9.04e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16145776	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs178659	MIMAT0005942	hsa-miR-1288-3p	3.98	9.04e-05	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16153128	chr17:16282058~16282078:+
KIRP	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-3.97	9.11e-05	-0.2	-0.24	Migraine;	chr10:103273258	chr10:103394341~103394361:-
KIRP	cis	rs7210990	0.836	rs11651290	MIMAT0005942	hsa-miR-1288-3p	3.97	9.12e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16048157	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs3815039	MIMAT0005942	hsa-miR-1288-3p	3.97	9.12e-05	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16049274	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.82	rs7013500	MIMAT0019728	hsa-miR-4660	3.97	9.19e-05	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9577492	chr8:9048453~9048475:+
KIRP	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	3.97	9.23e-05	0.37	0.24	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.909	rs4841179	MIMAT0019728	hsa-miR-4660	-3.97	9.25e-05	-0.33	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9602939	chr8:9048453~9048475:+
KIRP	cis	rs7982677	1	rs9584018	MIMAT0004491	hsa-miR-19b-1-5p	3.97	9.28e-05	0.25	0.24	Tetralogy of Fallot;	chr13:92324580	chr13:91351207~91351229:+
KIRP	cis	rs7829975	0.511	rs1401390	MIMAT0019728	hsa-miR-4660	3.97	9.32e-05	0.32	0.24	Mood instability;	chr8:8278888	chr8:9048453~9048475:+
KIRP	cis	rs10859871	1	rs4762340	MIMAT0000760	hsa-miR-331-3p	-3.97	9.37e-05	-0.17	-0.24	Endometriosis;	chr12:95294764	chr12:95308480~95308500:+
KIRP	cis	rs10859871	1	rs11107968	MIMAT0000760	hsa-miR-331-3p	-3.97	9.37e-05	-0.17	-0.24	Endometriosis;	chr12:95296668	chr12:95308480~95308500:+
KIRP	cis	rs10859871	1	rs4762342	MIMAT0000760	hsa-miR-331-3p	-3.97	9.37e-05	-0.17	-0.24	Endometriosis;	chr12:95297220	chr12:95308480~95308500:+
KIRP	cis	rs1355223	0.583	rs2941058	MIMAT0019776	hsa-miR-1343-3p	3.97	9.42e-05	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34858698	chr11:34941888~34941909:+
KIRP	cis	rs7829975	0.711	rs12682352	MIMAT0019728	hsa-miR-4660	3.96	9.46e-05	0.29	0.24	Mood instability;	chr8:8788736	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.67	rs6990418	MIMAT0019728	hsa-miR-4660	3.96	9.48e-05	0.31	0.24	Multiple myeloma (hyperdiploidy);	chr8:9564496	chr8:9048453~9048475:+
KIRP	cis	rs9394169	0.875	rs1547669	MIMAT0022975	hsa-miR-3934-3p	-3.96	9.49e-05	-0.28	-0.24	Essential tremor;	chr6:33807864	chr6:33698191~33698212:+
KIRP	cis	rs9394169	0.875	rs1547670	MIMAT0022975	hsa-miR-3934-3p	-3.96	9.49e-05	-0.28	-0.24	Essential tremor;	chr6:33808091	chr6:33698191~33698212:+
KIRP	cis	rs9329221	0.621	rs522483	MIMAT0019728	hsa-miR-4660	-3.96	9.57e-05	-0.3	-0.24	Neuroticism;	chr8:9955459	chr8:9048453~9048475:+
KIRP	cis	rs330048	0.509	rs36111783	MIMAT0019728	hsa-miR-4660	3.96	9.59e-05	0.32	0.24	Systemic lupus erythematosus;	chr8:9288078	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs10903315	MIMAT0019728	hsa-miR-4660	-3.96	9.6e-05	-0.33	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9626411	chr8:9048453~9048475:+
KIRP	cis	rs2055729	0.808	rs12550674	MIMAT0019728	hsa-miR-4660	-3.96	9.61e-05	-0.32	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9875989	chr8:9048453~9048475:+
KIRP	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-3.96	9.76e-05	-0.24	-0.24	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
KIRP	cis	rs1355223	0.583	rs2941041	MIMAT0019776	hsa-miR-1343-3p	3.95	0.000101	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34853187	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2941057	MIMAT0019776	hsa-miR-1343-3p	3.95	0.000101	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34860673	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.552	rs2421743	MIMAT0019776	hsa-miR-1343-3p	3.95	0.000101	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34861293	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2116085	MIMAT0019776	hsa-miR-1343-3p	3.95	0.000101	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34862454	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2915238	MIMAT0019776	hsa-miR-1343-3p	3.95	0.000101	0.3	0.24	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34862858	chr11:34941888~34941909:+
KIRP	cis	rs4427176	0.507	rs7462910	MIMAT0019728	hsa-miR-4660	3.95	0.000101	0.33	0.24	Mosquito bite size;	chr8:9722476	chr8:9048453~9048475:+
KIRP	cis	rs2953174	1	rs2953176	MIMAT0019954	hsa-miR-4786-5p	-3.95	0.000101	-0.41	-0.24	Bipolar disorder;	chr2:240581337	chr2:239943063~239943084:-
KIRP	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	3.95	0.000101	0.38	0.24	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
KIRP	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	3.94	0.000103	0.24	0.24	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
KIRP	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-3.94	0.000103	-0.15	-0.24	Migraine;	chr10:103395309	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-3.94	0.000103	-0.15	-0.24	Migraine;	chr10:103395888	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-3.94	0.000103	-0.15	-0.24	Migraine;	chr10:103278698	chr10:103394301~103394322:-
KIRP	cis	rs7477	0.56	rs11651578	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000103	0.27	0.24	Amyotrophic lateral sclerosis;	chr17:16284278	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.557	rs4792729	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000103	0.27	0.24	Amyotrophic lateral sclerosis;	chr17:16285105	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.557	rs3785625	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000103	0.27	0.24	Amyotrophic lateral sclerosis;	chr17:16287104	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs8080706	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000103	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16088246	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.766	rs12942295	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000104	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16070530	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs9891379	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000104	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073244	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs9898313	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000104	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073818	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs11657912	MIMAT0005942	hsa-miR-1288-3p	3.94	0.000104	0.28	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16052826	chr17:16282058~16282078:+
KIRP	cis	rs4851551	0.867	rs3917299	MIMAT0019926	hsa-miR-4772-5p	3.94	0.000104	0.41	0.24	Blood protein levels;	chr2:102169626	chr2:102432300~102432321:+
KIRP	cis	rs12545912	0.818	rs6601339	MIMAT0019728	hsa-miR-4660	3.94	0.000105	0.34	0.24	Multiple myeloma (hyperdiploidy);	chr8:9601039	chr8:9048453~9048475:+
KIRP	cis	rs9329221	0.683	rs658385	MIMAT0019728	hsa-miR-4660	-3.94	0.000105	-0.29	-0.24	Neuroticism;	chr8:10034667	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.821	rs10112600	MIMAT0019728	hsa-miR-4660	3.94	0.000106	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9604024	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.908	rs10097438	MIMAT0019728	hsa-miR-4660	3.94	0.000106	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9604182	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.863	rs10087749	MIMAT0019728	hsa-miR-4660	3.94	0.000106	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9604305	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.863	rs10112821	MIMAT0019728	hsa-miR-4660	3.94	0.000106	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9604373	chr8:9048453~9048475:+
KIRP	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-3.94	0.000106	-0.2	-0.24	Migraine;	chr10:103279291	chr10:103394341~103394361:-
KIRP	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000107	-0.15	-0.24	Migraine;	chr10:103293183	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000107	-0.15	-0.24	Migraine;	chr10:103293219	chr10:103394301~103394322:-
KIRP	cis	rs10492002	1	rs10492002	MIMAT0003287	hsa-miR-618	3.93	0.000107	0.27	0.24	Response to antidepressant treatment (citalopram);	chr12:81150757	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.863	rs4579533	MIMAT0019728	hsa-miR-4660	3.93	0.000107	0.33	0.24	Multiple myeloma (hyperdiploidy);	chr8:9611518	chr8:9048453~9048475:+
KIRP	cis	rs9329221	0.741	rs13264066	MIMAT0019728	hsa-miR-4660	-3.93	0.000107	-0.3	-0.24	Neuroticism;	chr8:9946565	chr8:9048453~9048475:+
KIRP	cis	rs9329221	0.741	rs9650622	MIMAT0019728	hsa-miR-4660	-3.93	0.000107	-0.3	-0.24	Neuroticism;	chr8:9946782	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs61176710	MIMAT0019728	hsa-miR-4660	-3.93	0.000107	-0.34	-0.24	Multiple myeloma (hyperdiploidy);	chr8:9628389	chr8:9048453~9048475:+
KIRP	cis	rs10859871	1	rs7308919	MIMAT0000760	hsa-miR-331-3p	3.93	0.000108	0.17	0.24	Endometriosis;	chr12:95316320	chr12:95308480~95308500:+
KIRP	cis	rs4906172	1	rs2253998	MIMAT0022697	hsa-miR-382-3p	-3.93	0.000108	-0.23	-0.24	Menopause (age at onset);	chr14:102030015	chr14:101054352~101054372:+
KIRP	cis	rs7210990	0.701	rs178802	MIMAT0005942	hsa-miR-1288-3p	3.93	0.000108	0.27	0.24	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16203731	chr17:16282058~16282078:+
KIRP	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000109	-0.15	-0.24	Migraine;	chr10:103375562	chr10:103394301~103394322:-
KIRP	cis	rs453301	0.686	rs17702602	MIMAT0019728	hsa-miR-4660	-3.93	0.000109	-0.3	-0.24	Joint mobility (Beighton score);	chr8:9051086	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs10103426	MIMAT0019728	hsa-miR-4660	3.92	0.000111	0.34	0.23	Multiple myeloma (hyperdiploidy);	chr8:9558748	chr8:9048453~9048475:+
KIRP	cis	rs41313321	0.505	rs2240953	MIMAT0019748	hsa-miR-219b-3p	3.92	0.000112	0.62	0.23	Coenzyme Q10 levels;	chr9:128348613	chr9:128392676~128392698:+
KIRP	cis	rs2624839	0.704	rs1046956	MIMAT0019957	hsa-miR-4787-3p	-3.92	0.000112	-0.29	-0.23	Intelligence (multi-trait analysis);	chr3:50185493	chr3:50675130~50675153:+
KIRP	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	3.92	0.000112	0.15	0.23	Migraine;	chr10:103237257	chr10:103394301~103394322:-
KIRP	cis	rs12545912	0.586	rs60674203	MIMAT0019728	hsa-miR-4660	-3.92	0.000112	-0.33	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9628177	chr8:9048453~9048475:+
KIRP	cis	rs3824488	0.599	rs16909859	MIMAT0004588	hsa-miR-27b-5p	-3.92	0.000112	-0.37	-0.23	Neuroticism;	chr9:95442510	chr9:95085463~95085484:+
KIRP	cis	rs7829975	0.714	rs4841040	MIMAT0019728	hsa-miR-4660	3.92	0.000112	0.29	0.23	Mood instability;	chr8:8797017	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.761	rs1906012	MIMAT0005909	hsa-miR-1258	3.92	0.000112	0.26	0.23	Blood protein levels;	chr2:179810942	chr2:179860845~179860865:-
KIRP	cis	rs7210990	0.931	rs11650427	MIMAT0005942	hsa-miR-1288-3p	3.92	0.000113	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16255460	chr17:16282058~16282078:+
KIRP	cis	rs4711336	1	rs2296742	MIMAT0022975	hsa-miR-3934-3p	-3.92	0.000114	-0.26	-0.23	Height;	chr6:33692016	chr6:33698191~33698212:+
KIRP	cis	rs4711336	1	rs764754	MIMAT0022975	hsa-miR-3934-3p	-3.92	0.000114	-0.26	-0.23	Height;	chr6:33690533	chr6:33698191~33698212:+
KIRP	cis	rs4711336	1	rs2229642	MIMAT0022975	hsa-miR-3934-3p	-3.91	0.000116	-0.26	-0.23	Height;	chr6:33691695	chr6:33698191~33698212:+
KIRP	cis	rs7829975	0.774	rs35039922	MIMAT0019728	hsa-miR-4660	3.91	0.000116	0.29	0.23	Mood instability;	chr8:8817815	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.863	rs7832096	MIMAT0019728	hsa-miR-4660	-3.91	0.000117	-0.33	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9605073	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.686	rs11787026	MIMAT0019728	hsa-miR-4660	3.91	0.000118	0.29	0.23	Joint mobility (Beighton score);	chr8:9044861	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.82	rs7844450	MIMAT0019728	hsa-miR-4660	3.91	0.000118	0.34	0.23	Multiple myeloma (hyperdiploidy);	chr8:9574600	chr8:9048453~9048475:+
KIRP	cis	rs10859871	1	rs10777683	MIMAT0000760	hsa-miR-331-3p	-3.91	0.000119	-0.17	-0.23	Endometriosis;	chr12:95306153	chr12:95308480~95308500:+
KIRP	cis	rs259842	0.67	rs13410767	MIMAT0005909	hsa-miR-1258	3.91	0.00012	0.25	0.23	Blood protein levels;	chr2:179803202	chr2:179860845~179860865:-
KIRP	cis	rs7210990	0.836	rs178829	MIMAT0005942	hsa-miR-1288-3p	3.9	0.00012	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16179875	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs9652828	MIMAT0005942	hsa-miR-1288-3p	3.9	0.00012	0.28	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16056400	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.557	rs11868284	MIMAT0005942	hsa-miR-1288-3p	3.9	0.000121	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16292961	chr17:16282058~16282078:+
KIRP	cis	rs10492002	1	rs1435964	MIMAT0003287	hsa-miR-618	-3.9	0.000122	-0.26	-0.23	Response to antidepressant treatment (citalopram);	chr12:81148436	chr12:80935796~80935818:-
KIRP	cis	rs7826238	0.535	rs2979179	MIMAT0019728	hsa-miR-4660	3.9	0.000122	0.29	0.23	Systolic blood pressure;	chr8:8462519	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.821	rs4372006	MIMAT0019728	hsa-miR-4660	3.9	0.000122	0.34	0.23	Multiple myeloma (hyperdiploidy);	chr8:9599835	chr8:9048453~9048475:+
KIRP	cis	rs2055729	0.885	rs13268133	MIMAT0019728	hsa-miR-4660	3.9	0.000122	0.31	0.23	Multiple myeloma (hyperdiploidy);	chr8:9873960	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.766	rs758853	MIMAT0005942	hsa-miR-1288-3p	3.9	0.000123	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16000288	chr17:16282058~16282078:+
KIRP	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000124	0.15	0.23	Migraine;	chr10:103241753	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000125	0.18	0.23	Migraine;	chr10:103248169	chr10:103394341~103394361:-
KIRP	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000125	0.18	0.23	Migraine;	chr10:103249329	chr10:103394341~103394361:-
KIRP	cis	rs7210990	0.836	rs8076864	MIMAT0005942	hsa-miR-1288-3p	-3.89	0.000126	-0.27	-0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16032956	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.909	rs10088037	MIMAT0019728	hsa-miR-4660	3.89	0.000127	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9610689	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs10088039	MIMAT0019728	hsa-miR-4660	3.89	0.000127	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9610694	chr8:9048453~9048475:+
KIRP	cis	rs2274459	0.572	rs116454384	MIMAT0022975	hsa-miR-3934-3p	3.89	0.000127	0.42	0.23	Obesity (extreme);	chr6:33678598	chr6:33698191~33698212:+
KIRP	cis	rs9329221	0.683	rs3105738	MIMAT0019728	hsa-miR-4660	-3.89	0.000127	-0.28	-0.23	Neuroticism;	chr8:10032404	chr8:9048453~9048475:+
KIRP	cis	rs7982677	1	rs9584017	MIMAT0004491	hsa-miR-19b-1-5p	3.89	0.000128	0.24	0.23	Tetralogy of Fallot;	chr13:92324128	chr13:91351207~91351229:+
KIRP	cis	rs4927850	1	rs6799572	MIMAT0003235	hsa-miR-570-3p	3.89	0.000128	0.3	0.23	Pancreatic cancer;	chr3:196013537	chr3:195699460~195699481:+
KIRP	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-3.89	0.000128	-0.24	-0.23	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
KIRP	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-3.89	0.000128	-0.24	-0.23	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
KIRP	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-3.89	0.000128	-0.24	-0.23	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
KIRP	cis	rs4711336	1	rs764752	MIMAT0022975	hsa-miR-3934-3p	-3.89	0.000128	-0.26	-0.23	Height;	chr6:33690289	chr6:33698191~33698212:+
KIRP	cis	rs12545912	0.525	rs6601374	MIMAT0019728	hsa-miR-4660	3.89	0.000129	0.35	0.23	Multiple myeloma (hyperdiploidy);	chr8:9846285	chr8:9048453~9048475:+
KIRP	cis	rs9329221	0.683	rs4598253	MIMAT0019728	hsa-miR-4660	-3.89	0.000129	-0.28	-0.23	Neuroticism;	chr8:10032794	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.818	rs4582568	MIMAT0019728	hsa-miR-4660	3.88	0.00013	0.34	0.23	Multiple myeloma (hyperdiploidy);	chr8:9600434	chr8:9048453~9048475:+
KIRP	cis	rs7826238	0.623	rs2976893	MIMAT0019728	hsa-miR-4660	-3.88	0.00013	-0.3	-0.23	Systolic blood pressure;	chr8:8480709	chr8:9048453~9048475:+
KIRP	cis	rs2048656	0.526	rs9650638	MIMAT0019728	hsa-miR-4660	-3.88	0.00013	-0.34	-0.23	Schizophrenia;	chr8:9668039	chr8:9048453~9048475:+
KIRP	cis	rs2048656	0.578	rs4841235	MIMAT0019728	hsa-miR-4660	-3.88	0.000131	-0.3	-0.23	Schizophrenia;	chr8:9825848	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.866	rs178820	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000132	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187471	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.831	rs545738	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000132	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187858	chr17:16282058~16282078:+
KIRP	cis	rs2980439	0.783	rs2955587	MIMAT0019728	hsa-miR-4660	3.88	0.000132	0.31	0.23	Neuroticism;	chr8:8240557	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.546	rs791903	MIMAT0022975	hsa-miR-3934-3p	3.88	0.000133	0.27	0.23	Plateletcrit;	chr6:33734868	chr6:33698191~33698212:+
KIRP	cis	rs7210990	0.8	rs4792711	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000134	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15996557	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs9899002	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000134	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16018105	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs3785633	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000134	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16022420	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs12451075	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000134	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16022719	chr17:16282058~16282078:+
KIRP	cis	rs7829975	0.514	rs2976926	MIMAT0019728	hsa-miR-4660	3.87	0.000135	0.3	0.23	Mood instability;	chr8:8404114	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.591	rs12677543	MIMAT0019728	hsa-miR-4660	3.87	0.000135	0.29	0.23	Mood instability;	chr8:8786764	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	3.87	0.000136	0.14	0.23	Migraine;	chr10:103240612	chr10:103394301~103394322:-
KIRP	cis	rs7829975	0.514	rs2976929	MIMAT0019728	hsa-miR-4660	3.87	0.000138	0.3	0.23	Mood instability;	chr8:8401202	chr8:9048453~9048475:+
KIRP	cis	rs2921073	0.509	rs2976931	MIMAT0019728	hsa-miR-4660	3.87	0.000138	0.3	0.23	Parkinson's disease;	chr8:8399807	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-3.87	0.000139	-0.15	-0.23	Migraine;	chr10:103284400	chr10:103394301~103394322:-
KIRP	cis	rs7210990	0.733	rs4239134	MIMAT0005942	hsa-miR-1288-3p	3.87	0.000139	0.28	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15980653	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.616	rs11651955	MIMAT0005942	hsa-miR-1288-3p	3.87	0.000139	0.27	0.23	Amyotrophic lateral sclerosis;	chr17:16332148	chr17:16282058~16282078:+
KIRP	cis	rs259842	0.729	rs1486233	MIMAT0005909	hsa-miR-1258	3.87	0.00014	0.26	0.23	Blood protein levels;	chr2:179839754	chr2:179860845~179860865:-
KIRP	cis	rs10021731	0.691	rs10015704	MIMAT0003242	hsa-miR-577	-3.86	0.000142	-0.28	-0.23	Optic disc area;	chr4:114507972	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.725	rs7665770	MIMAT0003242	hsa-miR-577	-3.86	0.000142	-0.28	-0.23	Optic disc area;	chr4:114508383	chr4:114656774~114656794:+
KIRP	cis	rs7829975	0.511	rs1543238	MIMAT0019728	hsa-miR-4660	3.86	0.000142	0.31	0.23	Mood instability;	chr8:8277287	chr8:9048453~9048475:+
KIRP	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	3.86	0.000142	0.37	0.23	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
KIRP	cis	rs6058526	1	rs6061196	MIMAT0015077	hsa-miR-3193	3.86	0.000143	0.28	0.23	Chronic obstructive pulmonary disease;	chr20:32159277	chr20:31607186~31607207:+
KIRP	cis	rs7829975	0.511	rs2948286	MIMAT0019728	hsa-miR-4660	3.86	0.000144	0.31	0.23	Mood instability;	chr8:8272638	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.564	rs2921057	MIMAT0019728	hsa-miR-4660	3.86	0.000144	0.3	0.23	Mood instability;	chr8:8461157	chr8:9048453~9048475:+
KIRP	cis	rs4728142	1	rs4728142	MIMAT0000259	hsa-miR-182-5p	3.86	0.000145	0.18	0.23	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease;	chr7:128933913	chr7:129770447~129770470:-
KIRP	cis	rs4711336	1	rs2296741	MIMAT0022975	hsa-miR-3934-3p	-3.85	0.000146	-0.26	-0.23	Height;	chr6:33691780	chr6:33698191~33698212:+
KIRP	cis	rs4711336	1	rs4711337	MIMAT0022975	hsa-miR-3934-3p	-3.85	0.000146	-0.26	-0.23	Height;	chr6:33692210	chr6:33698191~33698212:+
KIRP	cis	rs4711336	0.967	rs4711338	MIMAT0022975	hsa-miR-3934-3p	-3.85	0.000146	-0.26	-0.23	Height;	chr6:33692411	chr6:33698191~33698212:+
KIRP	cis	rs4711336	1	rs3818523	MIMAT0022975	hsa-miR-3934-3p	-3.85	0.000146	-0.26	-0.23	Height;	chr6:33692594	chr6:33698191~33698212:+
KIRP	cis	rs10492002	0.638	rs12816473	MIMAT0003287	hsa-miR-618	3.85	0.000149	0.26	0.23	Response to antidepressant treatment (citalopram);	chr12:81210642	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.909	rs4240626	MIMAT0019728	hsa-miR-4660	-3.85	0.000149	-0.32	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9613550	chr8:9048453~9048475:+
KIRP	cis	rs1355223	0.583	rs2941044	MIMAT0019776	hsa-miR-1343-3p	3.85	0.000149	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34845897	chr11:34941888~34941909:+
KIRP	cis	rs10492002	1	rs7132119	MIMAT0003287	hsa-miR-618	-3.85	0.000149	-0.27	-0.23	Response to antidepressant treatment (citalopram);	chr12:81155896	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.774	rs6980831	MIMAT0019728	hsa-miR-4660	3.85	0.00015	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9557880	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.514	rs2979151	MIMAT0019728	hsa-miR-4660	-3.85	0.00015	-0.3	-0.23	Mood instability;	chr8:8400509	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.542	rs9329202	MIMAT0019728	hsa-miR-4660	-3.85	0.000151	-0.33	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9554490	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.824	rs2367797	MIMAT0005909	hsa-miR-1258	3.84	0.000154	0.25	0.23	Blood protein levels;	chr2:179859783	chr2:179860845~179860865:-
KIRP	cis	rs330048	0.545	rs11249913	MIMAT0019728	hsa-miR-4660	-3.84	0.000155	-0.31	-0.23	Systemic lupus erythematosus;	chr8:9286011	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.782	rs61934663	MIMAT0003287	hsa-miR-618	3.84	0.000156	0.27	0.23	Response to antidepressant treatment (citalopram);	chr12:81212462	chr12:80935796~80935818:-
KIRP	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-3.84	0.000156	-0.15	-0.23	Migraine;	chr10:103273985	chr10:103394301~103394322:-
KIRP	cis	rs2048656	0.578	rs2090061	MIMAT0019728	hsa-miR-4660	-3.84	0.000157	-0.29	-0.23	Schizophrenia;	chr8:9823468	chr8:9048453~9048475:+
KIRP	cis	rs1355223	0.583	rs1828298	MIMAT0019776	hsa-miR-1343-3p	3.83	0.000157	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848892	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs1396881	MIMAT0019776	hsa-miR-1343-3p	3.83	0.000157	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848959	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2915179	MIMAT0019776	hsa-miR-1343-3p	3.83	0.000157	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34850396	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2956076	MIMAT0019776	hsa-miR-1343-3p	3.83	0.000157	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34852577	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs2941060	MIMAT0019776	hsa-miR-1343-3p	3.83	0.000157	0.29	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34857607	chr11:34941888~34941909:+
KIRP	cis	rs7829975	0.681	rs2271342	MIMAT0019728	hsa-miR-4660	3.83	0.000158	0.28	0.23	Mood instability;	chr8:8786428	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-3.83	0.000158	-0.15	-0.23	Migraine;	chr10:103299551	chr10:103394301~103394322:-
KIRP	cis	rs11121246	0.518	rs6684644	MIMAT0004557	hsa-miR-34a-3p	3.83	0.000159	0.3	0.23	Plateletcrit;	chr1:8850519	chr1:9151693~9151714:-
KIRP	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-3.83	0.00016	-0.15	-0.23	Migraine;	chr10:103309363	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-3.83	0.00016	-0.15	-0.23	Migraine;	chr10:103317367	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-3.83	0.00016	-0.15	-0.23	Migraine;	chr10:103319682	chr10:103394301~103394322:-
KIRP	cis	rs7210990	0.866	rs7216834	MIMAT0005942	hsa-miR-1288-3p	-3.83	0.000161	-0.26	-0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16129451	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.774	rs4582569	MIMAT0019728	hsa-miR-4660	3.82	0.000163	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9600519	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.782	rs1882180	MIMAT0003287	hsa-miR-618	3.82	0.000164	0.27	0.23	Response to antidepressant treatment (citalopram);	chr12:81209134	chr12:80935796~80935818:-
KIRP	cis	rs12545912	0.908	rs6994557	MIMAT0019728	hsa-miR-4660	-3.82	0.000165	-0.32	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9720720	chr8:9048453~9048475:+
KIRP	cis	rs2980439	0.557	rs2921056	MIMAT0019728	hsa-miR-4660	3.82	0.000167	0.29	0.23	Neuroticism;	chr8:8461672	chr8:9048453~9048475:+
KIRP	cis	rs7826238	0.524	rs2921055	MIMAT0019728	hsa-miR-4660	3.82	0.000167	0.29	0.23	Systolic blood pressure;	chr8:8461832	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.501	rs2980769	MIMAT0019728	hsa-miR-4660	3.82	0.000168	0.29	0.23	Mood instability;	chr8:8462781	chr8:9048453~9048475:+
KIRP	cis	rs10492002	1	rs12831934	MIMAT0003287	hsa-miR-618	3.82	0.000169	0.27	0.23	Response to antidepressant treatment (citalopram);	chr12:81155195	chr12:80935796~80935818:-
KIRP	cis	rs189798	1	rs189798	MIMAT0019728	hsa-miR-4660	-3.82	0.00017	-0.3	-0.23	Myopia (pathological);	chr8:9133067	chr8:9048453~9048475:+
KIRP	cis	rs1355223	0.583	rs2941043	MIMAT0019776	hsa-miR-1343-3p	-3.81	0.000171	-0.29	-0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34849447	chr11:34941888~34941909:+
KIRP	cis	rs10492002	0.853	rs61936383	MIMAT0003287	hsa-miR-618	3.81	0.000171	0.27	0.23	Response to antidepressant treatment (citalopram);	chr12:81176367	chr12:80935796~80935818:-
KIRP	cis	rs453301	0.522	rs1964356	MIMAT0019728	hsa-miR-4660	3.81	0.000173	0.3	0.23	Joint mobility (Beighton score);	chr8:8995760	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.636	rs7294617	MIMAT0003287	hsa-miR-618	3.81	0.000174	0.25	0.23	Response to antidepressant treatment (citalopram);	chr12:81111846	chr12:80935796~80935818:-
KIRP	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	3.81	0.000174	0.18	0.23	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
KIRP	cis	rs4921799	0.64	rs11203895	MIMAT0015020	hsa-miR-548v	-3.81	0.000174	-0.28	-0.23	Lung cancer;Adenocarcinoma;	chr8:17678085	chr8:17681588~17681609:-
KIRP	cis	rs2296887	0.591	rs7897947	MIMAT0022727	hsa-miR-1307-5p	-3.81	0.000175	-0.22	-0.23	Parkinson's disease;	chr10:102397954	chr10:103394341~103394361:-
KIRP	cis	rs7210990	0.766	rs3760298	MIMAT0005942	hsa-miR-1288-3p	3.81	0.000176	0.26	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16001876	chr17:16282058~16282078:+
KIRP	cis	rs12682352	0.652	rs1567398	MIMAT0019728	hsa-miR-4660	-3.8	0.000177	-0.29	-0.23	Neuroticism;	chr8:8869294	chr8:9048453~9048475:+
KIRP	cis	rs2953174	0.786	rs2975749	MIMAT0019954	hsa-miR-4786-5p	-3.8	0.000177	-0.4	-0.23	Bipolar disorder;	chr2:240579676	chr2:239943063~239943084:-
KIRP	cis	rs10492002	0.613	rs1921036	MIMAT0003287	hsa-miR-618	3.8	0.000179	0.24	0.23	Response to antidepressant treatment (citalopram);	chr12:81212083	chr12:80935796~80935818:-
KIRP	cis	rs12546962	0.639	rs56731460	MIMAT0019728	hsa-miR-4660	3.8	0.00018	0.38	0.23	Body mass index;	chr8:9337160	chr8:9048453~9048475:+
KIRP	cis	rs79724016	0.546	rs78410207	MIMAT0000693	hsa-miR-30e-3p	3.8	0.000181	0.4	0.23	Breast cancer;	chr1:41646956	chr1:40754413~40754434:+
KIRP	cis	rs79724016	0.744	rs7539225	MIMAT0000693	hsa-miR-30e-3p	3.8	0.000181	0.4	0.23	Breast cancer;	chr1:41647852	chr1:40754413~40754434:+
KIRP	cis	rs4713675	0.505	rs2395450	MIMAT0022975	hsa-miR-3934-3p	-3.8	0.000181	-0.27	-0.23	Plateletcrit;	chr6:33686811	chr6:33698191~33698212:+
KIRP	cis	rs4790312	0.513	rs12939002	MIMAT0000426	hsa-miR-132-3p	3.8	0.000181	0.27	0.23	Left atrial antero-posterior diameter;	chr17:2061802	chr17:2049929~2049950:-
KIRP	cis	rs9329221	0.619	rs591346	MIMAT0019728	hsa-miR-4660	-3.8	0.000181	-0.29	-0.23	Neuroticism;	chr8:9960555	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.602	rs2526398	MIMAT0019957	hsa-miR-4787-3p	3.8	0.000181	0.29	0.23	Intelligence (multi-trait analysis);	chr3:50150163	chr3:50675130~50675153:+
KIRP	cis	rs12545912	0.865	rs4493905	MIMAT0019728	hsa-miR-4660	3.8	0.000183	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9599827	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.818	rs4407883	MIMAT0019728	hsa-miR-4660	3.8	0.000183	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9600131	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.774	rs4621810	MIMAT0019728	hsa-miR-4660	3.8	0.000183	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9600522	chr8:9048453~9048475:+
KIRP	cis	rs259842	0.669	rs56388438	MIMAT0005909	hsa-miR-1258	3.79	0.000183	0.26	0.23	Blood protein levels;	chr2:179817826	chr2:179860845~179860865:-
KIRP	cis	rs7210990	0.866	rs11871961	MIMAT0005942	hsa-miR-1288-3p	3.79	0.000184	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16094112	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.569	rs2137790	MIMAT0019728	hsa-miR-4660	3.79	0.000184	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9850222	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11249941	MIMAT0019728	hsa-miR-4660	-3.79	0.000186	-0.32	-0.23	Mosquito bite size;	chr8:9700601	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.836	rs4791660	MIMAT0005942	hsa-miR-1288-3p	3.79	0.000186	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16056876	chr17:16282058~16282078:+
KIRP	cis	rs4427176	0.507	rs7837815	MIMAT0019728	hsa-miR-4660	-3.79	0.000187	-0.32	-0.23	Mosquito bite size;	chr8:9718627	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.546	rs10947430	MIMAT0022975	hsa-miR-3934-3p	-3.79	0.000188	-0.26	-0.23	Plateletcrit;	chr6:33690757	chr6:33698191~33698212:+
KIRP	cis	rs10859871	1	rs12298029	MIMAT0000760	hsa-miR-331-3p	-3.79	0.000188	-0.16	-0.23	Endometriosis;	chr12:95302028	chr12:95308480~95308500:+
KIRP	cis	rs10859871	1	rs1387047	MIMAT0000760	hsa-miR-331-3p	-3.79	0.000188	-0.16	-0.23	Endometriosis;	chr12:95304230	chr12:95308480~95308500:+
KIRP	cis	rs6601327	0.665	rs9286060	MIMAT0019728	hsa-miR-4660	-3.79	0.000189	-0.29	-0.23	Multiple myeloma (hyperdiploidy);	chr8:9795635	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.704	rs12632110	MIMAT0019957	hsa-miR-4787-3p	-3.79	0.000189	-0.28	-0.23	Intelligence (multi-trait analysis);	chr3:50186792	chr3:50675130~50675153:+
KIRP	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-3.79	0.00019	-0.14	-0.23	Migraine;	chr10:103270083	chr10:103394301~103394322:-
KIRP	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-3.78	0.000191	-0.18	-0.23	Migraine;	chr10:103278698	chr10:103394341~103394361:-
KIRP	cis	rs7072216	0.655	rs3830025	MIMAT0026738	hsa-miR-1287-3p	3.78	0.000191	0.21	0.23	Metabolite levels;	chr10:98416347	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.655	rs3830024	MIMAT0026738	hsa-miR-1287-3p	3.78	0.000191	0.21	0.23	Metabolite levels;	chr10:98416349	chr10:98395232~98395253:-
KIRP	cis	rs10021731	0.725	rs6850121	MIMAT0003242	hsa-miR-577	-3.78	0.000192	-0.28	-0.23	Optic disc area;	chr4:114484294	chr4:114656774~114656794:+
KIRP	cis	rs10021731	0.659	rs28564476	MIMAT0003242	hsa-miR-577	-3.78	0.000192	-0.28	-0.23	Optic disc area;	chr4:114484592	chr4:114656774~114656794:+
KIRP	cis	rs7829975	0.714	rs6994038	MIMAT0019728	hsa-miR-4660	3.78	0.000193	0.28	0.23	Mood instability;	chr8:8803028	chr8:9048453~9048475:+
KIRP	cis	rs2980439	0.783	rs2948305	MIMAT0019728	hsa-miR-4660	3.78	0.000193	0.3	0.23	Neuroticism;	chr8:8241055	chr8:9048453~9048475:+
KIRP	cis	rs2953174	0.786	rs2953146	MIMAT0019954	hsa-miR-4786-5p	3.78	0.000193	0.3	0.23	Bipolar disorder;	chr2:240575835	chr2:239943063~239943084:-
KIRP	cis	rs259842	0.8	rs1383413	MIMAT0005909	hsa-miR-1258	-3.78	0.000194	-0.24	-0.23	Blood protein levels;	chr2:179852906	chr2:179860845~179860865:-
KIRP	cis	rs1964356	0.967	rs17701675	MIMAT0019728	hsa-miR-4660	-3.78	0.000194	-0.29	-0.23	Mean corpuscular volume;	chr8:8993123	chr8:9048453~9048475:+
KIRP	cis	rs113027826	1	rs16838601	MIMAT0014995	hsa-miR-3130-5p	-3.78	0.000195	-0.52	-0.23	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206700272	chr2:206783276~206783296:-
KIRP	cis	rs113027826	1	rs16838601	MIMAT0014995_1	hsa-miR-3130-5p	-3.78	0.000195	-0.52	-0.23	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206700272	chr2:206783246~206783266:+
KIRP	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	3.78	0.000195	0.28	0.23	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
KIRP	cis	rs189798	0.807	rs9949	MIMAT0019728	hsa-miR-4660	3.78	0.000196	0.32	0.23	Myopia (pathological);	chr8:9137002	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.836	rs1079533	MIMAT0005942	hsa-miR-1288-3p	-3.78	0.000197	-0.27	-0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16046884	chr17:16282058~16282078:+
KIRP	cis	rs6601327	0.573	rs13278824	MIMAT0019728	hsa-miR-4660	3.77	0.000198	0.29	0.23	Multiple myeloma (hyperdiploidy);	chr8:9788609	chr8:9048453~9048475:+
KIRP	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000199	0.2	0.23	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
KIRP	cis	rs7210990	0.766	rs11651508	MIMAT0005942	hsa-miR-1288-3p	3.77	0.000199	0.27	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15988666	chr17:16282058~16282078:+
KIRP	cis	rs7909791	0.678	rs10883932	MIMAT0005951	hsa-miR-1307-3p	-3.77	0.000199	-0.18	-0.23	White matter hyperintensity burden;	chr10:103864198	chr10:103394301~103394322:-
KIRP	cis	rs12682352	0.652	rs3827806	MIMAT0019728	hsa-miR-4660	3.77	0.000201	0.28	0.23	Neuroticism;	chr8:8866766	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.909	rs4320547	MIMAT0019728	hsa-miR-4660	3.77	0.000202	0.33	0.23	Multiple myeloma (hyperdiploidy);	chr8:9610114	chr8:9048453~9048475:+
KIRP	cis	rs4727443	0.899	rs6954978	MIMAT0027650	hsa-miR-6875-5p	3.77	0.000204	0.28	0.23	Interstitial lung disease;	chr7:99984589	chr7:100868041~100868061:+
KIRP	cis	rs79724016	0.546	rs28684469	MIMAT0000693	hsa-miR-30e-3p	3.77	0.000204	0.4	0.23	Breast cancer;	chr1:41646520	chr1:40754413~40754434:+
KIRP	cis	rs10492002	0.563	rs4240725	MIMAT0003287	hsa-miR-618	-3.76	0.000207	-0.26	-0.23	Response to antidepressant treatment (citalopram);	chr12:81121267	chr12:80935796~80935818:-
KIRP	cis	rs6601327	0.67	rs7004937	MIMAT0019728	hsa-miR-4660	3.76	0.000207	0.29	0.23	Multiple myeloma (hyperdiploidy);	chr8:9563451	chr8:9048453~9048475:+
KIRP	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	3.76	0.000208	0.27	0.23	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
KIRP	cis	rs12682352	0.652	rs3789843	MIMAT0019728	hsa-miR-4660	3.76	0.000208	0.28	0.23	Neuroticism;	chr8:8866747	chr8:9048453~9048475:+
KIRP	cis	rs7072216	0.621	rs3750605	MIMAT0026738	hsa-miR-1287-3p	3.76	0.000209	0.21	0.23	Metabolite levels;	chr10:98415897	chr10:98395232~98395253:-
KIRP	cis	rs7909791	0.549	rs11191820	MIMAT0005951	hsa-miR-1307-3p	-3.76	0.000209	-0.16	-0.23	White matter hyperintensity burden;	chr10:103835097	chr10:103394301~103394322:-
KIRP	cis	rs9329221	0.678	rs560638	MIMAT0019728	hsa-miR-4660	-3.76	0.00021	-0.27	-0.23	Neuroticism;	chr8:10025257	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.704	rs12637671	MIMAT0019957	hsa-miR-4787-3p	-3.76	0.000211	-0.28	-0.23	Intelligence (multi-trait analysis);	chr3:50187129	chr3:50675130~50675153:+
KIRP	cis	rs453301	0.658	rs6983877	MIMAT0019728	hsa-miR-4660	-3.76	0.000211	-0.28	-0.23	Joint mobility (Beighton score);	chr8:9047129	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.888	rs35166008	MIMAT0003287	hsa-miR-618	3.76	0.000211	0.26	0.23	Response to antidepressant treatment (citalopram);	chr12:81177469	chr12:80935796~80935818:-
KIRP	cis	rs6601327	0.602	rs12678014	MIMAT0019728	hsa-miR-4660	3.76	0.000213	0.29	0.23	Multiple myeloma (hyperdiploidy);	chr8:9791655	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.658	rs12114954	MIMAT0019728	hsa-miR-4660	-3.76	0.000213	-0.28	-0.23	Joint mobility (Beighton score);	chr8:9047352	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.668	rs13103537	MIMAT0003242	hsa-miR-577	-3.75	0.000214	-0.28	-0.23	Optic disc area;	chr4:114495092	chr4:114656774~114656794:+
KIRP	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-3.75	0.000216	-0.23	-0.23	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
KIRP	cis	rs12546962	0.639	rs17149817	MIMAT0019728	hsa-miR-4660	3.75	0.000216	0.36	0.23	Body mass index;	chr8:9337503	chr8:9048453~9048475:+
KIRP	cis	rs2048656	0.526	rs6990779	MIMAT0019728	hsa-miR-4660	-3.75	0.000218	-0.32	-0.22	Schizophrenia;	chr8:9689900	chr8:9048453~9048475:+
KIRP	cis	rs4713675	0.584	rs560111	MIMAT0022975	hsa-miR-3934-3p	-3.75	0.000218	-0.26	-0.22	Plateletcrit;	chr6:33738500	chr6:33698191~33698212:+
KIRP	cis	rs6058526	0.631	rs3813922	MIMAT0015077	hsa-miR-3193	3.75	0.000219	0.29	0.22	Chronic obstructive pulmonary disease;	chr20:32189533	chr20:31607186~31607207:+
KIRP	cis	rs9329221	0.683	rs525726	MIMAT0019728	hsa-miR-4660	-3.75	0.000219	-0.27	-0.22	Neuroticism;	chr8:10030287	chr8:9048453~9048475:+
KIRP	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	3.75	0.00022	0.2	0.22	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
KIRP	cis	rs453301	0.686	rs6601281	MIMAT0019728	hsa-miR-4660	-3.75	0.000221	-0.29	-0.22	Joint mobility (Beighton score);	chr8:9053494	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.602	rs2526390	MIMAT0019957	hsa-miR-4787-3p	3.74	0.000222	0.29	0.22	Intelligence (multi-trait analysis);	chr3:50155327	chr3:50675130~50675153:+
KIRP	cis	rs12545912	0.525	rs7006923	MIMAT0019728	hsa-miR-4660	-3.74	0.000223	-0.33	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9869356	chr8:9048453~9048475:+
KIRP	cis	rs6695223	1	rs7527292	MIMAT0019232	hsa-miR-4423-5p	3.74	0.000224	0.36	0.22	Venous thromboembolism (SNP x SNP interaction);	chr1:85072207	chr1:85133806~85133827:+
KIRP	cis	rs259842	0.8	rs10930887	MIMAT0005909	hsa-miR-1258	-3.74	0.000225	-0.24	-0.22	Blood protein levels;	chr2:179849235	chr2:179860845~179860865:-
KIRP	cis	rs12545912	0.525	rs12543209	MIMAT0019728	hsa-miR-4660	-3.74	0.000225	-0.33	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9868683	chr8:9048453~9048475:+
KIRP	cis	rs113027826	1	rs113027826	MIMAT0014995	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206684788	chr2:206783276~206783296:-
KIRP	cis	rs113027826	1	rs113027826	MIMAT0014995_1	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206684788	chr2:206783246~206783266:+
KIRP	cis	rs113027826	1	rs79416952	MIMAT0014995	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206685201	chr2:206783276~206783296:-
KIRP	cis	rs113027826	1	rs79416952	MIMAT0014995_1	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206685201	chr2:206783246~206783266:+
KIRP	cis	rs113027826	1	rs75701478	MIMAT0014995	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206689703	chr2:206783276~206783296:-
KIRP	cis	rs113027826	1	rs75701478	MIMAT0014995_1	hsa-miR-3130-5p	-3.74	0.000226	-0.5	-0.22	Cerebrospinal fluid t-tau:AB1-42 ratio;	chr2:206689703	chr2:206783246~206783266:+
KIRP	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	3.74	0.000227	0.2	0.22	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
KIRP	cis	rs7210990	0.766	rs2779211	MIMAT0005942	hsa-miR-1288-3p	-3.74	0.000227	-0.26	-0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15972621	chr17:16282058~16282078:+
KIRP	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	3.74	0.000228	0.19	0.22	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
KIRP	cis	rs259842	0.669	rs6433810	MIMAT0005909	hsa-miR-1258	3.73	0.00023	0.25	0.22	Blood protein levels;	chr2:179829510	chr2:179860845~179860865:-
KIRP	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	3.73	0.000231	0.18	0.22	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
KIRP	cis	rs7909791	0.606	rs3814219	MIMAT0005951	hsa-miR-1307-3p	3.73	0.000231	0.19	0.22	White matter hyperintensity burden;	chr10:103887337	chr10:103394301~103394322:-
KIRP	cis	rs1355223	0.583	rs1553757	MIMAT0019776	hsa-miR-1343-3p	3.73	0.000233	0.28	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34845542	chr11:34941888~34941909:+
KIRP	cis	rs1355223	0.583	rs1549789	MIMAT0019776	hsa-miR-1343-3p	3.73	0.000233	0.28	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34846400	chr11:34941888~34941909:+
KIRP	cis	rs4921799	0.711	rs11203892	MIMAT0015020	hsa-miR-548v	3.73	0.000233	0.27	0.22	Lung cancer;Adenocarcinoma;	chr8:17676853	chr8:17681588~17681609:-
KIRP	cis	rs9663711	1	rs9663711	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000235	0.19	0.22	Carotid plaque burden;	chr10:102787871	chr10:103394341~103394361:-
KIRP	cis	rs1737890	0.778	rs6058684	MIMAT0015077	hsa-miR-3193	-3.73	0.000236	-0.27	-0.22	Chronic obstructive pulmonary disease;	chr20:32410413	chr20:31607186~31607207:+
KIRP	cis	rs6601327	0.571	rs7838571	MIMAT0019728	hsa-miR-4660	3.73	0.000236	0.28	0.22	Multiple myeloma (hyperdiploidy);	chr8:9790286	chr8:9048453~9048475:+
KIRP	cis	rs4927850	1	rs4927704	MIMAT0003235	hsa-miR-570-3p	3.73	0.000237	0.29	0.22	Pancreatic cancer;	chr3:196011357	chr3:195699460~195699481:+
KIRP	cis	rs4927850	1	rs4927848	MIMAT0003235	hsa-miR-570-3p	3.73	0.000237	0.29	0.22	Pancreatic cancer;	chr3:196011535	chr3:195699460~195699481:+
KIRP	cis	rs7826238	0.509	rs2948288	MIMAT0019728	hsa-miR-4660	3.73	0.000238	0.29	0.22	Systolic blood pressure;	chr8:8257782	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.543	rs11249948	MIMAT0019728	hsa-miR-4660	3.73	0.000238	0.29	0.22	Multiple myeloma (hyperdiploidy);	chr8:9791176	chr8:9048453~9048475:+
KIRP	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	3.73	0.000238	0.21	0.22	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
KIRP	cis	rs7829975	0.714	rs11784052	MIMAT0019728	hsa-miR-4660	3.73	0.000239	0.27	0.22	Mood instability;	chr8:8814452	chr8:9048453~9048475:+
KIRP	cis	rs9329221	0.65	rs657913	MIMAT0019728	hsa-miR-4660	-3.72	0.00024	-0.27	-0.22	Neuroticism;	chr8:10025065	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.853	rs34605308	MIMAT0003287	hsa-miR-618	3.72	0.00024	0.26	0.22	Response to antidepressant treatment (citalopram);	chr12:81165368	chr12:80935796~80935818:-
KIRP	cis	rs74233809	0.534	rs284841	MIMAT0022727	hsa-miR-1307-5p	3.72	0.00024	0.28	0.22	Birth weight;	chr10:102790322	chr10:103394341~103394361:-
KIRP	cis	rs74233809	0.534	rs284844	MIMAT0022727	hsa-miR-1307-5p	3.72	0.00024	0.28	0.22	Birth weight;	chr10:102794772	chr10:103394341~103394361:-
KIRP	cis	rs4713675	0.546	rs2296739	MIMAT0022975	hsa-miR-3934-3p	-3.72	0.000241	-0.26	-0.22	Plateletcrit;	chr6:33689192	chr6:33698191~33698212:+
KIRP	cis	rs4713675	0.546	rs3818521	MIMAT0022975	hsa-miR-3934-3p	-3.72	0.000241	-0.26	-0.22	Plateletcrit;	chr6:33689469	chr6:33698191~33698212:+
KIRP	cis	rs1355223	0.583	rs1396880	MIMAT0019776	hsa-miR-1343-3p	-3.72	0.000242	-0.28	-0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34849005	chr11:34941888~34941909:+
KIRP	cis	rs12545912	0.865	rs4240632	MIMAT0019728	hsa-miR-4660	-3.72	0.000243	-0.31	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9695481	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.904	rs10883863	MIMAT0005951	hsa-miR-1307-3p	3.72	0.000244	0.14	0.22	Migraine;	chr10:103402122	chr10:103394301~103394322:-
KIRP	cis	rs1737890	0.673	rs6119231	MIMAT0015077	hsa-miR-3193	3.72	0.000246	0.27	0.22	Chronic obstructive pulmonary disease;	chr20:32276789	chr20:31607186~31607207:+
KIRP	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000246	0.26	0.22	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
KIRP	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000246	0.26	0.22	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
KIRP	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-3.72	0.000248	-0.18	-0.22	Migraine;	chr10:103283532	chr10:103394341~103394361:-
KIRP	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-3.72	0.000248	-0.18	-0.22	Migraine;	chr10:103284207	chr10:103394341~103394361:-
KIRP	cis	rs10199359	0.945	rs1558644	MIMAT0019926	hsa-miR-4772-5p	3.72	0.000248	0.32	0.22	Pre-treatment pain in head and neck squamous cell carcinoma;	chr2:102074850	chr2:102432300~102432321:+
KIRP	cis	rs1018697	0.966	rs1475643	MIMAT0022727	hsa-miR-1307-5p	3.71	0.000249	0.19	0.22	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394341~103394361:-
KIRP	cis	rs2980439	0.557	rs2976876	MIMAT0019728	hsa-miR-4660	3.71	0.000253	0.28	0.22	Neuroticism;	chr8:8461340	chr8:9048453~9048475:+
KIRP	cis	rs1359742	0.702	rs9406787	MIMAT0004504	hsa-miR-31-3p	3.71	0.000253	0.16	0.22	Chronic lymphocytic leukemia;	chr9:22340160	chr9:21512121~21512142:-
KIRP	cis	rs12545912	0.525	rs582491	MIMAT0019728	hsa-miR-4660	-3.71	0.000253	-0.38	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9936593	chr8:9048453~9048475:+
KIRP	cis	rs1737890	0.778	rs1040751	MIMAT0015077	hsa-miR-3193	3.71	0.000254	0.26	0.22	Chronic obstructive pulmonary disease;	chr20:32441200	chr20:31607186~31607207:+
KIRP	cis	rs7477	1	rs7477	MIMAT0005942	hsa-miR-1288-3p	3.71	0.000254	0.25	0.22	Amyotrophic lateral sclerosis;	chr17:16342702	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.661	rs1079534	MIMAT0005942	hsa-miR-1288-3p	3.71	0.000255	0.27	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16045819	chr17:16282058~16282078:+
KIRP	cis	rs453301	0.686	rs7017868	MIMAT0019728	hsa-miR-4660	-3.71	0.000255	-0.27	-0.22	Joint mobility (Beighton score);	chr8:9015783	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.686	rs3895823	MIMAT0019728	hsa-miR-4660	-3.71	0.000255	-0.27	-0.22	Joint mobility (Beighton score);	chr8:9016136	chr8:9048453~9048475:+
KIRP	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000255	0.18	0.22	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
KIRP	cis	rs7210990	0.585	rs12939418	MIMAT0005942	hsa-miR-1288-3p	3.71	0.000256	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16127720	chr17:16282058~16282078:+
KIRP	cis	rs259842	0.663	rs10211004	MIMAT0005909	hsa-miR-1258	3.71	0.000256	0.24	0.22	Blood protein levels;	chr2:179822936	chr2:179860845~179860865:-
KIRP	cis	rs7210990	0.866	rs72833498	MIMAT0005942	hsa-miR-1288-3p	3.71	0.000256	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16092488	chr17:16282058~16282078:+
KIRP	cis	rs12546962	0.51	rs7836983	MIMAT0019728	hsa-miR-4660	3.71	0.000257	0.39	0.22	Body mass index;	chr8:9327420	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-3.71	0.000257	-0.14	-0.22	Migraine;	chr10:103389790	chr10:103394301~103394322:-
KIRP	cis	rs1737890	0.673	rs4413223	MIMAT0015077	hsa-miR-3193	3.7	0.000258	0.27	0.22	Chronic obstructive pulmonary disease;	chr20:32271164	chr20:31607186~31607207:+
KIRP	cis	rs4427176	0.507	rs4240629	MIMAT0019728	hsa-miR-4660	-3.7	0.000258	-0.31	-0.22	Mosquito bite size;	chr8:9695182	chr8:9048453~9048475:+
KIRP	cis	rs7477	0.557	rs4792731	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000258	0.26	0.22	Amyotrophic lateral sclerosis;	chr17:16298627	chr17:16282058~16282078:+
KIRP	cis	rs12545912	0.908	rs4535744	MIMAT0019728	hsa-miR-4660	-3.7	0.000261	-0.32	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9687039	chr8:9048453~9048475:+
KIRP	cis	rs4427176	0.507	rs11249938	MIMAT0019728	hsa-miR-4660	-3.7	0.000261	-0.32	-0.22	Mosquito bite size;	chr8:9687276	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.797	rs9903464	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000262	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16149067	chr17:16282058~16282078:+
KIRP	cis	rs1964356	0.967	rs2953802	MIMAT0019728	hsa-miR-4660	3.7	0.000262	0.29	0.22	Mean corpuscular volume;	chr8:8994371	chr8:9048453~9048475:+
KIRP	cis	rs12431410	0.55	rs11844387	MIMAT0022287	hsa-miR-5586-5p	-3.7	0.000262	-0.22	-0.22	Schizophrenia;	chr14:59758006	chr14:59646999~59647020:-
KIRP	cis	rs7210990	0.866	rs4791661	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16105394	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.766	rs9909697	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16116664	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.831	rs10852833	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16124047	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs9902141	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16131459	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs178658	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16154176	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.866	rs178657	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000264	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16154619	chr17:16282058~16282078:+
KIRP	cis	rs7829975	0.593	rs2921051	MIMAT0019728	hsa-miR-4660	3.7	0.000264	0.28	0.22	Mood instability;	chr8:8462594	chr8:9048453~9048475:+
KIRP	cis	rs10492002	0.566	rs1882189	MIMAT0003287	hsa-miR-618	3.7	0.000264	0.26	0.22	Response to antidepressant treatment (citalopram);	chr12:81215480	chr12:80935796~80935818:-
KIRP	cis	rs7982677	0.535	rs6492597	MIMAT0004491	hsa-miR-19b-1-5p	3.7	0.000266	0.22	0.22	Tetralogy of Fallot;	chr13:92312029	chr13:91351207~91351229:+
KIRP	cis	rs4728142	1	rs4728142	MIMAT0000095	hsa-miR-96-5p	3.7	0.000266	0.19	0.22	Systemic lupus erythematosus;Ulcerative colitis;Inflammatory bowel disease;	chr7:128933913	chr7:129774739~129774761:-
KIRP	cis	rs7477	0.586	rs12945877	MIMAT0005942	hsa-miR-1288-3p	3.69	0.000268	0.26	0.22	Amyotrophic lateral sclerosis;	chr17:16334889	chr17:16282058~16282078:+
KIRP	cis	rs10021731	0.691	rs2126027	MIMAT0003242	hsa-miR-577	-3.69	0.000269	-0.27	-0.22	Optic disc area;	chr4:114533510	chr4:114656774~114656794:+
KIRP	cis	rs4790312	0.935	rs3744274	MIMAT0000426	hsa-miR-132-3p	3.69	0.000269	0.24	0.22	Left atrial antero-posterior diameter;	chr17:2087665	chr17:2049929~2049950:-
KIRP	cis	rs7829975	0.774	rs11775523	MIMAT0019728	hsa-miR-4660	3.69	0.00027	0.28	0.22	Mood instability;	chr8:8821666	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.774	rs1039915	MIMAT0019728	hsa-miR-4660	3.69	0.00027	0.28	0.22	Mood instability;	chr8:8822104	chr8:9048453~9048475:+
KIRP	cis	rs453301	0.686	rs6601280	MIMAT0019728	hsa-miR-4660	3.69	0.000272	0.28	0.22	Joint mobility (Beighton score);	chr8:9051726	chr8:9048453~9048475:+
KIRP	cis	rs2624839	0.704	rs2624833	MIMAT0019957	hsa-miR-4787-3p	3.69	0.000272	0.28	0.22	Intelligence (multi-trait analysis);	chr3:50175079	chr3:50675130~50675153:+
KIRP	cis	rs7829975	0.517	rs12542733	MIMAT0019728	hsa-miR-4660	-3.69	0.000273	-0.27	-0.22	Mood instability;	chr8:8967348	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.542	rs34324628	MIMAT0019728	hsa-miR-4660	3.69	0.000273	0.31	0.22	Multiple myeloma (hyperdiploidy);	chr8:9556993	chr8:9048453~9048475:+
KIRP	cis	rs7829975	0.714	rs12544992	MIMAT0019728	hsa-miR-4660	3.69	0.000275	0.27	0.22	Mood instability;	chr8:8804171	chr8:9048453~9048475:+
KIRP	cis	rs6601327	0.67	rs12545250	MIMAT0019728	hsa-miR-4660	3.69	0.000275	0.28	0.22	Multiple myeloma (hyperdiploidy);	chr8:9563056	chr8:9048453~9048475:+
KIRP	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-3.69	0.000276	-0.18	-0.22	Migraine;	chr10:103284400	chr10:103394341~103394361:-
KIRP	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	3.69	0.000277	0.2	0.22	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
KIRP	cis	rs10021731	0.725	rs1551742	MIMAT0003242	hsa-miR-577	3.69	0.000277	0.28	0.22	Optic disc area;	chr4:114485894	chr4:114656774~114656794:+
KIRP	cis	rs453301	0.658	rs9650616	MIMAT0019728	hsa-miR-4660	-3.68	0.000279	-0.27	-0.22	Joint mobility (Beighton score);	chr8:9011689	chr8:9048453~9048475:+
KIRP	cis	rs2980439	0.818	rs2945249	MIMAT0019728	hsa-miR-4660	3.68	0.000279	0.29	0.22	Neuroticism;	chr8:8237204	chr8:9048453~9048475:+
KIRP	cis	rs1737890	0.778	rs6058689	MIMAT0015077	hsa-miR-3193	-3.68	0.00028	-0.27	-0.22	Chronic obstructive pulmonary disease;	chr20:32423563	chr20:31607186~31607207:+
KIRP	cis	rs9329221	0.683	rs688491	MIMAT0019728	hsa-miR-4660	-3.68	0.000281	-0.27	-0.22	Neuroticism;	chr8:10027313	chr8:9048453~9048475:+
KIRP	cis	rs7210990	0.866	rs178816	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000282	0.25	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16189588	chr17:16282058~16282078:+
KIRP	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	3.68	0.000282	0.2	0.22	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	3.68	0.000282	0.2	0.22	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	3.68	0.000282	0.2	0.22	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
KIRP	cis	rs2048656	0.578	rs925610	MIMAT0019728	hsa-miR-4660	-3.68	0.000283	-0.28	-0.22	Schizophrenia;	chr8:9824326	chr8:9048453~9048475:+
KIRP	cis	rs10859871	0.76	rs11107973	MIMAT0000760	hsa-miR-331-3p	-3.68	0.000284	-0.16	-0.22	Endometriosis;	chr12:95308609	chr12:95308480~95308500:+
KIRP	cis	rs7210990	0.836	rs2157992	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000284	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16025571	chr17:16282058~16282078:+
KIRP	cis	rs7477	0.555	rs1476810	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000284	0.25	0.22	Amyotrophic lateral sclerosis;	chr17:16329903	chr17:16282058~16282078:+
KIRP	cis	rs4427176	0.507	rs6601348	MIMAT0019728	hsa-miR-4660	-3.68	0.000285	-0.31	-0.22	Mosquito bite size;	chr8:9712984	chr8:9048453~9048475:+
KIRP	cis	rs7909791	0.743	rs12776760	MIMAT0005951	hsa-miR-1307-3p	-3.67	0.000289	-0.18	-0.22	White matter hyperintensity burden;	chr10:103867817	chr10:103394301~103394322:-
KIRP	cis	rs453301	0.686	rs28665409	MIMAT0019728	hsa-miR-4660	-3.67	0.00029	-0.27	-0.22	Joint mobility (Beighton score);	chr8:9011767	chr8:9048453~9048475:+
KIRP	cis	rs2801405	0.941	rs11189770	MIMAT0026738	hsa-miR-1287-3p	3.67	0.000291	0.25	0.22	Obesity-related traits;	chr10:98719569	chr10:98395232~98395253:-
KIRP	cis	rs2048656	0.526	rs12545912	MIMAT0019728	hsa-miR-4660	3.67	0.000291	0.31	0.22	Schizophrenia;	chr8:9744189	chr8:9048453~9048475:+
KIRP	cis	rs7982677	0.535	rs7997136	MIMAT0004491	hsa-miR-19b-1-5p	3.67	0.000293	0.22	0.22	Tetralogy of Fallot;	chr13:92318354	chr13:91351207~91351229:+
KIRP	cis	rs7072216	0.621	rs3750605	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000294	0.27	0.22	Metabolite levels;	chr10:98415897	chr10:98395271~98395292:-
KIRP	cis	rs4927850	1	rs7625570	MIMAT0003235	hsa-miR-570-3p	3.67	0.000294	0.28	0.22	Pancreatic cancer;	chr3:196020527	chr3:195699460~195699481:+
KIRP	cis	rs12682352	0.605	rs60707155	MIMAT0019728	hsa-miR-4660	3.67	0.000294	0.3	0.22	Neuroticism;	chr8:8866905	chr8:9048453~9048475:+
KIRP	cis	rs6762477	0.748	rs11714286	MIMAT0019957	hsa-miR-4787-3p	-3.67	0.000299	-0.27	-0.22	Menarche (age at onset);	chr3:50148075	chr3:50675130~50675153:+
KIRP	cis	rs7829975	0.714	rs4840362	MIMAT0019728	hsa-miR-4660	-3.66	0.000301	-0.27	-0.22	Mood instability;	chr8:8812572	chr8:9048453~9048475:+
KIRP	cis	rs12545912	0.569	rs509820	MIMAT0019728	hsa-miR-4660	-3.66	0.000301	-0.37	-0.22	Multiple myeloma (hyperdiploidy);	chr8:9936583	chr8:9048453~9048475:+
KIRP	cis	rs10021731	0.725	rs1460770	MIMAT0003242	hsa-miR-577	-3.66	0.000301	-0.27	-0.22	Optic disc area;	chr4:114484189	chr4:114656774~114656794:+
KIRP	cis	rs2624839	0.629	rs2526397	MIMAT0019957	hsa-miR-4787-3p	-3.66	0.000302	-0.28	-0.22	Intelligence (multi-trait analysis);	chr3:50150357	chr3:50675130~50675153:+
KIRP	cis	rs4790312	0.513	rs2232486	MIMAT0000426	hsa-miR-132-3p	3.66	0.000302	0.26	0.22	Left atrial antero-posterior diameter;	chr17:2065689	chr17:2049929~2049950:-
KIRP	cis	rs10021731	0.725	rs2126026	MIMAT0003242	hsa-miR-577	-3.66	0.000303	-0.27	-0.22	Optic disc area;	chr4:114533531	chr4:114656774~114656794:+
KIRP	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
KIRP	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	3.66	0.000303	0.19	0.22	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
KIRP	cis	rs7210990	0.836	rs2051736	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000303	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16086699	chr17:16282058~16282078:+
KIRP	cis	rs7210990	0.836	rs1125156	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000303	0.26	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16091240	chr17:16282058~16282078:+
KIRP	trans	rs10435736	0.673	rs4879523	MIMAT0000417	hsa-miR-15b-5p	6.51	3.78e-10	0.41	0.37	Metabolite levels  (X-11787);	chr9:31534675	chr3:160404607~160404628:+
KIRP	trans	rs2952768	0.686	rs7569963	MIMAT0018203	hsa-miR-676-5p	-6.35	9.17e-10	-0.47	-0.36	Opioid sensitivity;	chr2:207608460	chrX:70022864~70022884:+
KIRP	trans	rs6495122	0.532	rs2470890	MIMAT0022721	hsa-miR-1247-3p	-5.83	1.59e-08	-0.29	-0.34	Coffee consumption;Caffeine consumption;Diastolic blood pressure;	chr15:74755085	chr14:101560326~101560349:-
KIRP	trans	rs6977660	0.77	rs10224061	MIMAT0000101	hsa-miR-103a-3p	-5.77	2.19e-08	-0.25	-0.33	Thyroid stimulating hormone;	chr7:19812996	chr20:3917541~3917563:+
KIRP	trans	rs6977660	0.77	rs10224061	MIMAT0000101_1	hsa-miR-103a-3p	-5.77	2.19e-08	-0.25	-0.33	Thyroid stimulating hormone;	chr7:19812996	chr5:168560904~168560926:-